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Preface 
An agreement has been signed by the Dutch Expert Committee on Occupational 
Safety (DECOS) of the Health Council of the Netherlands and the Nordic Expert 
Group for Criteria Documentation of Health Risks from Chemicals (NEG). The 
purpose of the agreement is to write joint scientific criteria documents, which 
could be used by the national regulatory authorities in both the Netherlands and 
in the Nordic countries. 
The document on endotoxins is an update of a report published by the Dutch 
Health Council in 1998 and has been reviewed by DECOS as well as by NEG. 
The members of both committees are listed in Appendix 1. The first draft of this 
report was prepared by B. van de Ven and G. Speijers from the National Institute  
of Public Health and the Environment (RIVM), Bilthoven, the Netherlands. The 
joint document is published separately by DECOS and NEG. The NEG version 
presented herein has been adapted to the requirements of NEG and the format of 
Arbete och Hälsa. Editorial work and technical editing has been carried out by 
Anna-Karin Alexandrie and Jill Järnberg, scientific secretaries of NEG, at the 
Swedish Work Environment Authority. 
NEG is financially supported by the Swedish Work Environment Authority  
and the Norwegian Ministry of Labour. 
 
 
 
 
G. J. Mulder      G. Johanson  
Chairman      Chairman 
DECOS      NEG 
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ASTM American Society for Testing and Materials 
BAL bronchoalveolar lavage 
CI confidence interval 
COPD chronic obstructive pulmonary disease 
CRP C-reactive protein 
DECOS Dutch Expert Committee on Occupational Safety 
ECP eosinophilic cationic protein 
EN Committee Européen de Normalisation (European Committee on 
Standardisation) 
EU endotoxin unit/s 
FEF25–75 forced expiratory flow at 25–75 % of FVC (same as MMEF) 
FEV1 forced expiratory volume in 1 second (1
st
 second after full aspiration) 
ΔFEV1 (across-shift) change in FEV1 over an exposure period of several hours 
FVC forced vital capacity 
GM geometric mean 
GSD geometric standard deviation 
Ig immunoglobulin 
IHD ischaemic heart disease 
IL interleukin 
LAL Limulus amebocyte lysate 
LPS lipopolysaccharide/s 
MEFx maximal expiratory flow rate at x % of FVC 
MMEF maximal midexpiratory flow (average expiratory flow over middle 
half of FVC, same as FEF25–75) 
MPO myeloperoxidase 
NAL nasal lavage 
NEN Nederlands Normalisatie Instituut 
NF-κB nuclear factor kappa B 
ODTS organic dust toxic syndrome 
OEL occupational exposure limit 
OR odds ratio 
PC provocative concentration 
PEF peak expiratory flow 
PM10 particulate matter < 10 µm in aerodynamic diameter 
PMN polymorphonuclear leukocyte, i.e. neutrophil 
RR relative risk (risk ratio) 
SE standard error 
SMR standard mortality ratio 
Th T-helper cell 
TLR Toll-like receptor 
TNFα tumour necrosis factor alpha 
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1. Introduction 
Endotoxins are components of the outer membrane of Gram-negative bacteria  
and have been recognised as an important biologically active component in most 
organic dusts. Such bacteria-containing dust particles originate mainly from 
animal faeces and contaminated plant materials. Occupational exposure to endo-
toxins therefore occurs primarily in the agriculture industry and related sectors.  
To our knowledge, no occupational exposure limits for airborne endotoxins have 
yet been established. 
The present document is a co-production between the Nordic Expert Group for 
Criteria Documentation of Health Risks from Chemicals (NEG) and the Dutch 
Expert Committee on Occupational Safety (DECOS), hereafter called the com-
mittees. The document is an update of a previous endotoxin report of the Health 
Council of the Netherlands published in 1998 (41). The joint document is pub-
lished separately, and according to different formats, by DECOS (42) and NEG.  
It was concluded in the previous Health Council’s advice (41) that the most sen-
sitive health effect appeared to be acute and chronic bronchial obstruction, which 
can be measured by a decrease in FEV1. Such changes, at low or moderate ex-
posure levels, are at focus in this document, whereas other effects, e.g. respiratory 
symptoms, are mentioned but not covered in full.  
2. Identity, properties and monitoring 
If not stated otherwise, information in this chapter is a summary of data from the 
previous endotoxin report of the Health Council of the Netherlands (41). 
2.1 Chemical identity and physical and chemical properties 
Endotoxins are components of the external membrane of most Gram-negative 
bacteria. Bacteria naturally release small quantities of endotoxins as they re-
plicate, and the whole membrane content is released upon death and subsequent 
cell lysis. “Endotoxin” describes the molecule in situ, when still associated with 
proteins and other molecules of the bacterial membrane. The endotoxin molecules 
can be obtained by purification and are referred to as lipopolysaccharides (LPS). 
For further details, see the Health Council’s report from 1998 (41). 
LPS are stable water-soluble molecules composed of lipids and polysaccharides. 
In water, LPS usually convert into insoluble aggregates. The lipid moiety of LPS, 
a phosphoglycolipid, is termed “lipid A” and is a major contributor to the toxic 
properties of LPS. The hydrophilic polysaccharide moiety is composed of O-
specific side chains (O-antigens) and core sugars. The composition of the core is 
relatively constant and usually contains 2-keto-3-deoxy-D-manno-octulosonic 
acid (KDO). The O-specific side chain is a heteropolysaccharide consisting of re-
peating units of up to eight sugar monomers. Among various bacterial species, the 
composition of lipid A is remarkably constant, whereas the O-specific side chains 
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vary considerably. For further details, see the Health Council’s report from 1998 
(41).  
Endotoxins are relatively heat stable. The temperature reported to inactivate 
LPS is 177 °C (40), and LPS are stable at 121 °C for at least 1 hour (2). It is 
estimated that a single cell of Salmonella contains 10 femtograms (10 × 10
-15
 g)  
of LPS (2), which is 4 % of the total bacterial weight. Aggregations of endotoxins 
in aqueous solution can have a mass of 1 000 000 Dalton. Upon the application of 
surfactants such as sodium dodecyl sulphate, individual monomers may form with 
molecular weights of approximately 2 500–25 000 Dalton (136). 
2.2 European Union classification and labelling 
Endotoxins are naturally occurring substances and have not been classified and 
labelled by the European Union. 
2.3 Analytical methods 
Endotoxin levels in air can be measured either in absolute terms or as functional 
(bioactive) units per cubic metre of air. Endotoxin weight/m
3
 can be measured by 
use of gas chromatography combined with mass spectrometry (GC-MS). Functional 
endotoxin levels can be measured by use of the Limulus amebocyte lysate (LAL)-
assay and are expressed as endotoxin units (EU)/m
3
. In the LAL-assay, the reaction 
between endotoxins in the sample and a pro-enzyme purified from horseshoe crab 
(Limulus) amebocytes (blood cells) is measured. Subsequent coagulation can be 
evaluated by an increase in optical density measured spectrophotometrically. Test 
values are read from a standard endotoxin calibration curve. A range of LAL-
assay reagents is now available as kits, and the two main test types are endpoint 
and kinetic tests (65, 136). An additional feature of the most widely used chromo-
genic test variant is that it improves detection in more highly diluted samples, 
hence avoiding the disadvantage of dose-dependent inhibition by interfering agents. 
Table 1 shows a comparison between the older and more recent protocols for 
measuring endotoxin levels in air. 
As endotoxin air levels measured in a functional assay correlate better with 
toxic effects than air levels measured in weight/m
3
 (64), the chromogenic LAL-
test is the most accepted assay for endotoxin exposure measurements. The de-
tection limit of measurement of airborne environmental endotoxin is at present 
approximately 0.05 EU/m
3
 (43). 
In 2003, a NEN-EN (Nederlands Normalisatie Instituut-Committee Européen 
de Normalisation (European Committee on Standardisation)) 14031 protocol was 
published concerning a standardised method for the extraction and analyses of 
endotoxin concentrations in the environment (55). 
Despite the specificity of the LAL-method, significant differences in calculated 
levels of exposure have been reported by different laboratories analysing the same 
samples, as demonstrated by several round robin studies. A round robin study 
allows an evaluation of a test method by examining two parameters critical to any  
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Table 1. Comparison between analytical methods used for determining occupational 
endotoxin levels.
1
 
  Method described by Method used by 
 Spaan et al,  
2007 (125) 
Castellan et al,  
1987 (13) 
Smid et al, 1992 (120), 
Post et al, 1998 (98) 
Sample    
Dust fraction Inhalable dust Inhalable dust Inhalable dust 
Filter type Glass fibre Teflon Glass fibre 
Extraction and storage   
Storage temp. filter -18 ºC 4 ºC 4 ºC 
Extraction solution Pyrogenic water  
with 0.05 % Tween 
Pyrogenic and  
sterile water 
Pyrogenic and  
sterile water 
Storage temp. -18 ºC No storage No storage 
Defrost yes/no No Not stated Not stated 
Analyses    
Material Not stated Plastic Not stated 
Analyses In pyrogenic water 
without Tween 
In pyrogenic water 
without Tween 
In pyrogenic water  
without Tween 
LAL-test type Not stated Pyrostat test Kabi Vitrum test 
LAL: Limulus amebocyte lysate. 
 
test method: inter-laboratory and intra-laboratory variation. In one study, the per-
formance of six laboratories using their own laboratory specific protocol for older 
endpoints and newer kinetic versions of the Limulus-based assays for analysis of 
organic dusts from three agricultural environments (chicken, swine and corn) was 
compared. This comparison revealed 10-fold differences in measured endotoxin 
concentrations between laboratories. Precision of assays performed within labora-
tories was very good, with pooled coefficients of variation for replicate samples 
ranging from 1 to 11 % over all laboratories and all dust types (105). In another 
round robin study, 13 laboratories measured endotoxin concentrations that also 
varied up to a factor 10, despite the use of a common procedure for extraction of 
endotoxins from cotton dust (18). The variation in endotoxin concentration in 20 
samples measured by three laboratories, all using the NEN-EN 14031 protocol for 
extraction and analyses, was smaller, maximally a factor 4.2 between the different 
laboratories (55). Therefore, it was concluded in several studies that a reliable 
assessment of exposure to endotoxin activity is only possible when standard 
operation procedures for sampling and determination are established (70, 126). On 
the other hand, Spaan et al, 2008, also showed using an endotoxin exposure data-
base (with a fairly similar protocol for exposure measurement) that the analytical 
error for endotoxins is generally less than 20 %. In addition, the authors concluded 
that most of the variability in endotoxin exposure is an inherent part of the true 
exposure. This is presumably caused by the fact that endotoxins originate from 
Gram-negative bacteria, which grow and amplify (126). 
According to Rylander, 2002, the results of the LAL-test also depend on the 
physical state of the endotoxins in the sample. If they are present in a water solu-
tion, the values represent all of the endotoxins present in the sample. If the analysis 
                                      
1
 Adapted from data provided by Industox as comment on the DECOS public draft. 
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is made on a dust sample where endotoxins are still part of fragments of an intact 
bacterial cell wall, the results of the LAL-test may underestimate the total amount 
of bioactive material. Some attempts have been made to calculate the relation 
between the amounts detected in the analysis of dust and the bioactive amount, 
suggesting a ratio of 1:10 (107). 
In conclusion, the present NEN-EN procedure still leaves some aspects of the 
protocol open for interpretation by individual laboratories. Nevertheless, the com-
mittees emphasise that airborne endotoxin exposure should be assessed using 
standardised methods. Two extensive studies (funded by the Dutch Government 
under supervision of the Ministry of Social Affairs and Employment) investigated 
the gaps in the NEN-EN protocol and presented several adjustments to the guide-
line protocol for further standardisation. One specific development on these topics 
requires consideration. Optimally, extraction should be performed using a diluted 
detergent (e.g. Tween), while analysis should be undertaken in pyrogen free water 
to decrease potential interference with a diluted detergent. For some sectors of 
industry, systematic differences might be observed depending on procedures, pro-
bably because of matrix effects. This should be established on a case by case basis 
(70, 124, 125). The committees recommend to adapt these adjustments of Spaan et 
al, 2007 (125), in the NEN-EN protocol. 
Finally, in the earlier versions of the LAL-assays, the relation between EU and 
the amount of endotoxins in weight is that 1 EU is usually considered equivalent 
to 0.1 ng, although this is dependent on the potency of the specific species of endo-
toxins used to create the standard curve (65). 
Moreover, the committees are aware that the more recent versions of the LAL-
assay (NEN-EN protocol and Spaan et al, 2007 (125)) are more sensitive in 
measuring the endotoxin exposure. Compared to these recent protocols, the older 
assays most likely underestimated the endotoxin exposure levels (104, 105, 124, 
125). 
2.4 Environmental and occupational monitoring 
Workplace monitoring of endotoxins is usually performed by sampling airborne 
inhalable dust with a subsequent aqueous extraction. Dust is sampled on filters 
using pumps to draw air through the filters. Repeated freeze-thaw cycles might 
reduce the detectable endotoxin level. Furthermore, the committees are of the 
opinion that since endotoxins are components of growing microorganisms, the 
variation in exposure is expected to be higher for endotoxins than for other com-
pounds at the workplace. Therefore, in order to determine the exposure, the com-
mittees recommend to monitor endotoxin air levels more frequently than normally 
applied for workplace control measurements (124). 
The American Society for Testing and Materials (ASTM) has recently approved 
an endotoxin standard, i.e. “Standard test method for determination of endotoxin 
concentration”. While this standard provides an improved consensus method to 
measure endotoxin concentrations in bulk metal working fluid samples, it does  
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not address the issue of airborne endotoxin aerosolised from metal working fluid. 
Presently, there are no data concerning the relationship between endotoxin in bulk 
metal fluids and endotoxin concentrations in metal working fluid aerosols generated 
during machine operations. In addition, the ASTM approved a “Standard practice 
for personal sampling and analysis of endotoxin in metal working fluid aerosols in 
workplace atmospheres” (131).  
2.5 Recommendations 
In the former report of the Health Council (41), recommendations on procedures 
for collection, storage, extraction and analysis of airborne dust samples for endo-
toxins were made. In 2003, a NEN-EN 14031 protocol was published. Spaan et al, 
2007 investigated the gaps in this NEN-EN protocol and presented several adjust-
ments to the guideline protocol for further standardisation (125). The committees 
recommend to adapt these adjustments in the NEN-EN protocol and recommend 
further standardisation. 
3. Sources 
The protection of workers against toxic effects of endotoxins in occupational 
settings primarily concerns airborne exposure. Endotoxins become airborne 
during manufacturing or handling of organic materials. Endotoxin exposure is 
therefore most relevant in agricultural and related industries such as pig, chicken, 
cow and horse farming, grain elevators, cotton and linen industry, potato pro-
cessing industry, poultry slaughterhouse, animal feed industry, water sewage 
treatment and sewage composting plants, garbage handling facilities, organic 
waste composition facilities, wood chip composting and timber storing facilities. 
Endotoxin exposure seems mainly associated with organic dust exposure. Although 
organic dust has a heterogeneous composition, endotoxins have been recognised 
to be a very important biologically active component in most organic dusts (41). 
4. Exposure 
4.1 Environmental exposure 
Water 
In the report of the Health Council from 1998, one publication on endotoxin levels  
in lake and tap water in Finland was available. More than 100 people in one com-
munity in Finland experienced respiratory health problems after inhaling aqueous 
aerosol from an endotoxin contaminated drinking water source. Analyses of tap 
and lake water revealed endotoxin concentrations ranging from 200 to 1 000 ng/ml. 
These concentrations were exceptionally high and situations like that were con-
sidered not likely to occur in the Netherlands (41).  
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Since 1998, new data has become available. In studies reviewed by Anderson  
et al, 2002, it was indicated that endotoxin levels in raw (untreated) water ranged 
from < 1 to 1 050 ng/ml (< 10–10 500 EU/ml), but were mostly below 50 ng/ml 
(500 EU/ml). Values approaching 38 000 EU/ml were reported in a cyanobacterial 
bloom. In distribution systems containing drinking water obtained from surface 
water, the endotoxin content ranged from 0.8 to 11.4 ng/ml (8–114 EU/ml), where-
as it ranged from 1 to 3 ng/ml (10–30 EU/ml) (n = 60) when obtained from ground-
water. Water treatment plants can remove up to 97 % of the endotoxin levels by 
coagulation, flocculation and sedimentation. Ozonation reduce concentrations 
maximally by only 10 %, whereas chlorination did not reduce endotoxin levels (2). 
Food 
In the report of the Health Council from 1998, it was stated that actual endotoxin 
levels in human diet were not known. In a pig study, high dietary doses of endo-
toxins did not cause clinical symptoms (41). It therefore seemed justified that, al-
though there are no intake data, the oral route is not likely to be a relevant route  
of exposure. Since 1998, no further data has become available. 
Air 
In the report of the Health Council from 1998, it was concluded that relevant air-
borne exposure was mainly limited to occupational environments (41). However, 
the general population is exposed to endotoxins to a small extent as endotoxins are 
a component of house dust. The general population may further be exposed to en-
dotoxins when living in the vicinity of agricultural and related industries that emit 
organic dust to the environment.  
Since 1998, new exposure data on the general population has become available. 
Endotoxin levels in outdoor air were recently measured at 13 different locations in 
Southern California, United States. The 24-hour levels of PM10 (particulate matter 
below 10 μm in aerodynamic diameter) and the associated endotoxin component 
were measured once every 6 weeks for one year. The geometric mean ± geometric 
standard deviation (GM ± GSD) of endotoxin levels was 0.44 ± 3.1 EU/m
3
 (range 
0.03–5.5 EU/m3). Endotoxin concentrations differed significantly across regions 
as shown by the fact that GM levels by sampling site were 0.19–1.85 EU/m3 (90). 
A small measurement series was also reported by Schulze et al, 2006 (111). 
Indoor airborne endotoxin levels were measured in a 14-month study in 20 
homes and ranged from 0.02 to 19.8 EU/m
3
 (0.002–1.98 ng/m3) (95). Endotoxins 
in indoor air are suspected of playing a role in “sick building syndrome”. Con-
centrations were highest in the spring and lowest in the winter and were not well 
correlated with endotoxin concentrations in settled dust (108). Similar air levels 
have been observed in Dutch homes (93). Woskie et al, 1996, reported an expo-
sure of 1.9 ± 6.4 EU/m
3
 (0.19 ± 0.64 ng/m
3
, GM ± GSD) in office workers (n = 34) 
(140). Wan et al, 1999, reported a mean endotoxin concentration of 0.065 ng/m
3
  
(0.65 EU/m
3
) in houses (133). 
Hasday et al, 1999, reported that high bacterial endotoxin levels are present in 
cigarette smoke. Smoke from one cigarette contained 120 ng (1 200 EU) of bio-
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active LPS (40). The committees estimated that smoking of e.g. one pack of 20 
cigarettes/day (20 × 120 = 2 400 ng endotoxins) is comparable to an occupational 
LPS exposure of 240 ng/m
3
 for 8 hours a day (assuming a ventilation rate of 10 
m
3
 per 8 hours).  
4.2 Occupational exposure 
The exposure data in various occupational environments which were available for 
the 1998 evaluation were tabulated in the previous report of the Health Council 
(41). The exposure data, which has become available since, are summarised in 
Table 2. The exposure data found by Dutkiewicz et al, 2001 (27-29), are rather 
high compared to other studies in similar industry branches, which might be due 
to the fact that Dutkiewicz et al boiled the samples for 15 minutes at 100 °C to 
dissolve the endotoxins before testing.  
5. Kinetics 
5.1 Absorption, distribution and elimination 
Inhaled endotoxins can deposit at each level of the respiratory tract. If deposited 
in the trachea and large bronchi, particles are eliminated by mucociliary transport. 
Smaller particles deposit in the deeper airways where endotoxins can generate in-
flammatory reactions. Although Hjelle et al, 2000, reported that systemic uptake 
of nanoparticles and nanobacteria is possible, inhaled endotoxins are phagocytised 
by macrophages and have been assumed not to enter the bloodstream (49, 103, 107). 
Therefore, systemic effects due to inhaled endotoxins are most likely induced by 
cytokines that are released from the lung into the blood. There is, however, one 
recent study in which LPS in plasma were detected after occupational exposure to 
endotoxins at a mean level of 430 EU/m
3
 (114).  
For more information on absorption, distribution and elimination of endotoxins, 
the committees refer to the previous report of the Health Council (41). 
5.2 Possibilities for biological monitoring 
Markers of the local endotoxin-induced inflammatory response, like cytokines and 
inflammatory cells, can be investigated in bronchoalveolar lavage (BAL), nasal 
lavage (NAL), induced sputum and in blood. No attempts to determine endotoxin 
levels in BAL, NAL and induced sputum have been made (41, 103). In the afore-
mentioned study in which circulating LPS in plasma of exposed workers were de-
tected, LPS levels did not correlate with airborne endotoxin levels. This might be 
due to the rapid clearance of LPS from blood (114). However, the committees are 
of the opinion that the usefulness of these methods for monitoring is limited be-
cause clinical inflammatory responses are only expected after exposure to high 
endotoxin concentrations.   
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Table 2. Endotoxin concentrations in various occupational environments. 
Source/ 
industry 
Sampling 
method 
No. of 
samples 
Dust 
(mg/m
3
) 
Mean/median (range) 
(EU/m
3
) 
a
 
Mea-
sure 
Ref. 
Vegetable sources       
Cotton       
Mill Area 5 nd 110 (19–2 230) MD (64) 
Mill Personal 4 nd 1 200 (140–9 600) MD (64) 
Spinning Personal 31 1.1 4 540 (2 950–6 980) GM (116) 
Weaving Personal 36 0.59 50 (30–80) GM (116) 
Textile factory Personal 61 1.1 2 566
 
(5–36 397) b GM (56) 
Hemp/jute        
Jute batching Personal 3 9.4 23 190 (2 200–44 200) AM (15) 
Jute spinning Personal 2 2.2 9 560 (4 400–14 900) AM (15) 
Jute weaving Personal 2 1.8 410 (71–750) AM (15) 
Hemp Personal - 29.5
 c
 19 569
 b, c
 AM (65) 
Herbs       
11 herbs
 d
, 2 sites Area 10 18 112 000 (2 000–7 568 000) MD (28) 
Grain       
Storage houses Area 5 nd 170 000 (17 000–380 000) MD (64) 
(grain/onions) Personal 4 nd 56 000 (40 000–80 000) MD (64) 
Silos/flour mill Personal 31 4.4 1 150 (550–2 400) GM (116) 
Silos containing corn Area 15 3.3 983
 
(58–77 006) b GM (10) 
 Area 14 1.0
 c
 526
 
(55–3 733) b, c GM (10) 
Farms cultivating corn Area 14 3.4 3 175
 
(499–54 653) b GM (10) 
 Area 16 2.4
 c
 2 534
 
(284–29 266) b, c GM (10) 
Grain seed and legumes       
Dutch, overall Personal 188 1.5 580 (2.3–149 060) GM (127) 
Mushroom       
Cultivation/picking Personal 30 0.69 70 (50–110) GM (116) 
Potato       
Processing (sorting,  Personal 7 nd 195
 
(26–1 123) b MD (53) 
cleaning, trimming) Area 8 nd 222
 
(7–5 363) b MD (53) 
Cucumber and tomato       
Nurseries Personal 70 1.6 320 (5–4 000) MD (75) 
Wood       
Logging site Personal 7 0.56 15 (9.9–23) GM (1) 
Sawmill Personal 93 1.6 43 (1.9–780) GM (1) 
Joinery Personal 66 3.7 24 (1.0–280) GM (1) 
Sawmill Personal 37 1.5 190 (130–230) GM (116) 
Green mill Personal 55 1.5 66 (1.9–780) GM (78) 
 Personal 20 0.19
 c
 14 (1–53) c GM (78) 
Dry mill Personal 28 1.7 16 (5.1–56) GM (78) 
 Personal 10 0.46
 c
 1.4
 
(1–3.3) c GM (78) 
Pine sawmill Area 1 15 2 400 S (27) 
Fir sawmill Area 1 69 40 000 S (27) 
Fibreboard factory Area 100 0.4–36 16–1 974 b R (29) 
Chipboard factory Area 140 1.1–29 < 0.13–217 b R (29) 
3 pulp/paper mills Area 22 nd 33 (1–510) MD (64)  
 Personal 11 nd 60 (10–360) MD (64)  
2 pulp/paper mills Area 10 0.1–3.9 210 (42–25 000) MD (99) 
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Table 2. Endotoxin concentrations in various occupational environments. 
Source/ 
industry 
Sampling 
method 
No. of 
samples 
Dust 
(mg/m
3
) 
Mean/median (range) 
(EU/m
3
) 
a
 
Mea-
sure 
Ref. 
Animal sources       
Animal production        
Dutch, overall Personal 108 0.7 110 (2.0–8 120) GM (127) 
Cow       
85 barns (mostly dairy  Personal 194 1.8 647
 
(25–34 800) b GM (63) 
barns) Area 216 0.07
 c
 16.8
 
(0.16–1 380) b, c GM (63) 
Poultry       
Catching/shackling Personal 33 10.6 84 310 (53 130–133 860) GM (116) 
Slaughterhouse, 2 sites Area 10  nd 1 900 (0.2–9 400) MD (64) 
(reindeer, poultry) Personal 6  nd 870 (14–5 200) MD (64) 
Swine       
11 buildings Personal 27 5.8 6 600 (4 070–10 700) GM (116) 
8 buildings Area 8 3.3 390
 
(215–596) b MD (20) 
Open-style buildings Area 60 0.24 140
 
(14–818) b AM (14) 
 Area 95 0.14
 c
 47 (0.02–1 643) b, c AM (14) 
Wool       
Combing/weaving Personal 28 3.9 830 (360–1 900) GM (116) 
Other/mixed sources       
Animal feed       
3 plants Area 13  nd 65 (3–200) MD (64) 
 Personal 17  nd 190 (2–500) GM (116) 
 Personal 6 6.0 300 (110–800) GM (116) 
Fibreglass wool       
 Area 50  nd 10–3 900 (GSD 26–55) GM e (87) 
 Personal 390  nd 58–360 (GSD 26–34) GM e (87) 
Metal working fluid       
 Area 4  nd 67 (16–270) MD (64) 
 Personal 72 0.18 7.1 (GSD 4.7)
 b
 GM (140) 
 Area 9–12  nd 0.5–3 (< 0.1–100) MD (71) 
Printing       
Printing plant Area 5  nd 0.5 (0.3–1) MD (64) 
Sewage/waste water treatment plants 
67 Dutch plants  Personal 460  27 (0.6–2 093) GM (123) 
Plants - -  - 1 000–7 800 R (91) 
8 plants  - -  - 20–640 R (91) 
9 plants - -  - 40–321 700 R (91) 
Waste       
Garbage handling Area 8  nd 1 200 (9–14 000) MD (64) 
 Personal 1  nd 2 600  S (64) 
Recycling Personal 165 0–62 80 (2–1 980)  MD (37) 
Refuse-derived fuel Personal 78 0.50 29
 
(5–346) b GM (77) 
Waste collectors Personal 47 0.58 39
 
(4–7 182) b GM (141) 
Glass bottle recycling 
(at point of sale) 
Personal 182 0.18 3.6
 
(< 0.1–180) b GM (58) 
a 
1 endotoxin unit (EU)/m
3
 is approximately 0.1 ng/m
3
 endotoxin. 
b 
Levels reported in EU/m
3
 in the original reference. Remaining levels were calculated using a de-
fault conversion factor 10 (1 ng = 10 EU). 
c 
Measured in the respiratory fraction. 
d 
Nettle, caraway, birch, celandine, marjoram, mint, peppermint, sage, St John’s wort, calamus and 
yarrow. 
e 
Range of GMs of 4 areas. 
-: no information, AM: arithmetic mean, EU: endotoxin unit, GM: geometric mean, GSD: geometric 
standard deviation, MD: median, nd: not determined, R: range of means per site, S: single value. 
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6. Mechanism of action 
When endotoxins are inhaled, the lipid A part of the endotoxins is opsonised by a 
LPS binding protein present in the fluid on the airway surface. This LPS binding 
protein may act as a transporter to deliver endotoxins to cell membrane protein 
CD14, present on alveolar macrophages, monocytes and to a lesser extent on 
neutrophils. CD14 is the primary binding site for LPS, and is also present in a 
free, soluble form in the extracellular compartment (and thus in normal alveolar 
fluid) where it facilitates the attachment of endotoxins to endothelial cells, epi-
thelial cells and antigen presenting dendritic cells. Before soluble or membrane-
bound CD14-mediated cell-activation takes place, co-activation of a Toll-like-
receptor (TLR) seems to be required although the exact mechanism has not yet 
been revealed. In macrophages and epithelium cells, TLR4, and in dendritic  
cells, TLR3, play a role in the activation of these cells (107).  
Alveolar macrophages and type-II epithelial cells are the predominant airway 
cells stimulated by inhaled endotoxins. Their stimulation produces many cyto-
kines, chemokines, adhesion molecules and other products that cause inflammation, 
especially by recruiting and activating polymorphonuclear leukocytes (PMNs), i.e. 
neutrophils. 
When endotoxins are internalised by alveolar macrophages, nuclear factor kappa 
B (NF-κB) initiates the production of inflammatory cytokines like interleukin (IL)-
1β, IL-6, IL-8 and tumour necrosis factor alpha (TNFα). Production of metabolites 
of arachidonic acid by macrophages is also up-regulated, as well as the production 
of inducible nitric oxide synthase, leading to release of nitric oxide. IL-8 is the cyto- 
kine that induces the migration of the PMNs into the lung. Elastase produced by 
activated neutrophils is considered to be the primary factor responsible for the loss 
of elastic fibres in lung parenchyma and the development of emphysema. Elastase is 
also a potent stimulus of mucus secretion (103). 
Systemic effects are most likely induced by release of the cytokines into the 
blood. Inhaled endotoxins are assumed not to pass into the vascular department  
to any great extent, although Hjelle et al, 2000, reported that systemic uptake of 
nanoparticles and nanobacteria is possible (49, 103, 107). The cytokines produced 
are potential activators of the hepatic acute-phase protein response, as they stimu-
late hepatocytes. Airway exposure to endotoxins results in elevated blood con-
centrations of C-reactive protein (CRP) and LPS binding protein within 48 hours 
(85). This systemic inflammatory response is related to the dose of inhaled endo-
toxins and to endotoxin-induced fever. 
7. Effects 
Numerous studies have been published concerning the health effects of occupa-
tional exposure to endotoxins. Most of these studies deal with the adverse re-
spiratory health consequences. However, it has also been suggested that exposure 
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to endotoxins might protect against the development of atopy and atopic (allergic) 
asthma. Furthermore, repeated exposure to endotoxins might cause tolerance to 
acute effects. 
In this chapter, all these consequences of occupational exposure to endotoxins 
will be discussed in more detail. Adequate animal studies on effects similar to 
those observed in humans following endotoxin exposure and allowing a quantita-
tive hazard assessment based on dose-effect/response relationships for endotoxins 
are not available. 
7.1 Introduction 
Airborne endotoxin exposure has been shown to generate (local and systemic) 
biological and clinical effects in man. The main target organ is the lung. Inhaled 
endotoxins induce an inflammatory response in the lung that is characterised by 
influx of neutrophils and increased levels of cytokines in the bronchoalveolar com-
partment. Endotoxins will probably not enter the blood after inhalatory exposure 
to any great extent. The systemic effects like fever, malaise and headache occur at 
higher exposure levels. These effects are most likely mediated by locally produced 
cytokines that are released into the blood and not by the endotoxins themselves. 
The inflammatory reaction can lead to acute (respiratory and systemic) effects 
including fever, shivering, dry cough, chest tightness (byssinosis), dyspnoea, joint 
aches and influenza-like symptoms, which are all symptoms of the organic dust 
toxic syndrome (ODTS). Epidemiological and animal studies suggest that chronic 
exposure to endotoxins may lead to symptoms indicative of chronic bronchitis and 
asthma and reduced lung function, most likely via chronic inflammation. In case 
of prolonged exposure, an accelerated decline in lung function and increased bron-
chial reactivity can lead to chronic obstructive pulmonary disease (COPD). The 
global initiative for chronic obstructive lung disease (GOLD) has published an 
extensive review on COPD. COPD has two components, chronic bronchitis and 
emphysema. In this context, chronic bronchitis is of relevance. Its pulmonary com-
ponent is characterised by airflow limitation that is not fully reversible. The air-
flow limitation is usually progressive and associated with abnormal inflammatory 
response of the lung to noxious particles or gases (101). It can be measured with 
spirometry. Parameters that are considered as primary indicators of lung function 
are forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC). 
FEV1 is the maximal amount of air that can be expired with force in the first 
second after full inspiration (measured in litres) and FVC is the total amount of  
air that can be expired with force after full inspiration (measured in litres). The 
ratio FEV1/FVC shows the amount of the FVC that can be expelled in one second. 
In healthy adults, this should be approximately 80 % or more. In patients with 
COPD, the FEV1/FVC ratio is typically below 0.7 and this is accompanied by a 
FEV1 < 80 % of predicted FEV1 based on the mean FEV1 of healthy non-smoking 
persons at that age, sex and length. COPD is classified as moderate or worse de-
pending on the level of FEV1.  
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It was concluded in the previous Health Council’s advice that the most critical 
effects for human risk assessment are local effects in the lung (41). The most sen-
sitive health effect appeared to be acute and chronic bronchial obstruction, which 
can be measured by a decrease in FEV1. An acute effect is measured by a change 
in FEV1 over exposure on one day, and is denoted by ΔFEV1. For example, the 
change in FEV1 measured before and after a workshift of 4 or 8 hours is denoted 
as the “across-shift ΔFEV1”. Chronic effects are monitored by the (mean) change 
in FEV1 measured over a year (annual FEV1 change).  
7.2 Acute and short-term exposure  
Long-term or multiple exposures to endotoxins may lead to some kind of tolerance 
to acute clinical effects (38). However, after ending the exposure, this tolerance 
disappears in a few days (e.g. weekend). Tolerance development might obscure 
the actual dose-effect/dose-response curve. Therefore, effects after acute exposure 
to endotoxins might differ between workers who have been exposed in the past 
and healthy volunteers which have not been exposed before. This should be taken 
into account in the interpretation of the studies described in this section.  
Furthermore, in studies where subjects are exposed to single doses of nebulised 
LPS, comparison with a dose per m
3
 is difficult. Different dosing (exposure) and 
dose (exposure) metrics represent additional challenges for interpreting and com-
paring various studies of exposure to endotoxin. In some studies, subjects have 
been exposed to dosing with nebulised agents for short periods (i.e. minutes). 
While the concentration of the agent in the aqueous medium is typically given, 
other details (e.g. nebulisation rate and duration) are not provided. Moreover, the 
agents used in these nebulisation studies differ. Some have used suspensions of 
organic dust and others have used more purified endotoxin or LPS preparations. 
Regardless of the details provided for nebulisation studies, their results are diffi-
cult to compare with results from studies involving more prolonged (e.g. hours) 
exposure to airborne endotoxin containing organic dust. The latter studies are 
much more comparable to endotoxin exposures in occupational settings. 
7.2.1 Biological responses 
In a number of studies, local endotoxin-induced inflammatory responses have 
been investigated by studying BAL, NAL and induced sputum after endotoxin 
exposure. Systemic responses were investigated in blood. Most of these biological 
responses do not necessarily result in clinical responses.  
Single dose studies in healthy volunteers are summarised in Table 3. Biological 
responses to endotoxin exposure have also been examined in field studies. Effects 
were measured within a period of one week and were compared to those in healthy 
non-occupationally exposed controls. Results are shown in Table 4. 
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Table 3. Biological effects caused by single dose endotoxins in healthy volunteers. 
Dose No. of  Effects Measured  Ref. 
  µg  EU subjects  after  
0.1 1 000 16
 a
 NAL: No effect observed 4–24 h (96) 
0.3 3 000  NAL: No effect observed (NOAEL)   
1.0 10 000  NAL: Eosinophils ↑ (atopics only)   
0.5 5 000 9 Blood: PMNs ↓ 6 h (85) 
5 50 000  Blood: PMNs ↑, CRP ↑ 
Sputum: PMNs ↑, monocytes ↑, MPO ↑ 
  
50 500 000  Sputum: Lymphocytes ↑, TNFα ↑, ECP ↑   
5.4 54 000 14 BAL: Total cells ↑, TNFα ↑, IL-1β ↑, IL-6 ↑, IL-8 ↑ 4 h (54) 
36 360 000  FEV1 ↓   
40 400 000 21 Blood: PMNs ↑, MPO ↑,  
Sputum: PMNs ↑, ECP ↑ and MPO ↑ 
FEV1 2 % ↓ 
24 h (130) 
100 1 000 000 8 BAL: PMNs ↑ 3 h (129) 
a 
of which 10 atopic subjects. 
BAL: bronchoalveolar lavage, CRP: C-reactive protein (acute phase protein), ECP: eosinophilic 
cationic protein, EU: endotoxin unit, FEV1: forced expiratory volume in 1 second, IL: interleukin, 
MPO: myeloperoxidase, NAL: nasal lavage, NOAEL: no observed adverse effect level, PMN: 
polymorphonuclear leukocyte, i.e. neutrophil, TNFα: tumour necrosis factor alpha. 
 
 
Table 4. Biological effects caused by acute/short-term endotoxin occupational exposure. 
Study design/ 
population 
Work 
history 
Endotoxin  
level 
Parameters  
measured 
Effects Ref. 
4-day follow-up, 
cotton workers,  
n = 25 
controls, n = 9 
(scientists) 
> 8 
yrs 
Range 
1–400 EU/m3 
(0.1–40 ng/m3) 
Blood: CD14 
receptor on 
monocytes 
CD14 ↑ at the end 
of the 1st day, but 
back to normal  
at the end of the 
week. 
(35) 
1-week follow-up, 
domestic waste 
collectors, n = 47 
controls, n = 15  
(office workers) 
5 
yrs 
GM (range)  
39 (4–7 182) EU/m3 
(3.9 (0.4–718) ng/m3) 
NAL: IL-6, IL-
8, IL-1β, TNFα, 
cell counts and 
differentials.  
Serum: IgE 
IL-8 ↑ (1.8×) and 
total cell ↑ (3.3×)  
at the end of the 
week. 
(141) 
4-day follow-up, 
waste handlers,  
n = 31 
no controls 
1.5 
yrs 
Median (range) 
13 (4–183) EU/m3 
(1.3 (0.4–18.3) ng/m3) 
NAL: MPO, 
ECP, IL-8,  
cell counts and 
differentials 
ECP ↑ (1.8×) and 
% PMNs ↑ (1.6×) 
at the end of the 
week. 
(46) 
ECP: eosinophilic cationic protein, EU: endotoxin unit, GM: geometric mean, Ig: immuno-
globulin, IL: interleukin, MPO: myeloperoxidase, NAL: nasal lavage, PMN: polymorphonuclear 
leukocyte, i.e. neutrophil, TNFα: tumour necrosis factor alpha. 
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7.2.2 Acute effects on lung function 
Health Council report, 1998  
Studies on acute effects described in the previous Health Council report from 
1998 (41) which yielded a no observed adverse effect level (NOAEL) are briefly 
summarised below and in Table 5. 
In a study from 1985 by Rylander et al, 15 cotton mill workers (of whom 8 
persons had a history of byssinosis) were exposed in an experimental card room to 
cotton dust for 4 hours on Monday morning. Endotoxin concentrations ranged from 
70 to 5 620 ng/m
3
 (700–56 200 EU/m3) (personal sampling). FEV1 was determined 
before and after carding. A correlation was found between endotoxin exposure and 
ΔFEV1 over the exposure period. The authors calculated an endotoxin concentration 
of 33 ng/m
3
 (330 EU/m
3
) at which average FEV1 changes were zero using indivi-
dual FEV1 changes and ambient endotoxin concentrations in a regression analysis 
(equation: % ΔFEV1 = -3.43 × elog (endotoxin concentration in µg/m3) - 11.68,  
r = -0.56 (109). 
In a study from 1987 by Castellan et al, healthy volunteers (smoking and non-
smoking) were selected from the general population. They were not occupationally 
exposed to substances known to affect airway response and had an FEV1 above 
80 % of the predicted value. In addition, the volunteers were pre-tested by expo-
sure to 100 ng/m
3
 of LPS in order to select sensitive subjects. Only volunteers that 
responded with an FEV1 decrease of at least 5 % (and not more than 30 %) were 
accepted for the main study. The main study started with 61 (34 smokers) sub-
jects, but during the 20-month study period the number of participating subjects 
decreased to 33 (16 smokers) for a variety of reasons, none of which were related 
to the responsiveness to cotton dust. In 108 different exposure sessions, volunteers 
(24–35 subjects) were exposed to cotton dust during 6 hours, with airborne endo-
toxin concentrations ranging from 6 to 779 ng/m
3
 (60–7 790 EU/m3). Each session 
was followed by at least two full days without exposure. The authors found an ex-
posure-effect relation between ΔFEV1 and endotoxin concentration (ng/m
3
) of: 
% ΔFEV1 = 3.84 - 4.02 (
10
log endotoxin), r = 0.85 (r
2
 = 0.72), p < 0.0001. Another 
66 sessions of exposure of the same subjects to clean air resulted in a mean ΔFEV1 
of ± 0 %. The linear regression model yielded a zero percentage change in FEV1  
at 9 ng/m
3
 (90 EU/m
3
). In contrast, dust exposure (instead of endotoxin exposure) 
was not correlated with ΔFEV1 (13). 
The difference between the calculated zero-change level in Rylander’s study 
(33 ng/m
3
) (109) and the one in Castellan’s study (9 ng/m3) (13) might be due  
to different exposure times (4 vs. 6 hours). In addition, in Castellan’s study the 
responsiveness was enhanced for the assessment of acute airway responses by 
selecting responsive subjects during pre-screening. Furthermore, the population  
of Rylander’s study consisted of cotton mill workers who had been occupationally 
exposed to the same agent for years. As long-term exposure might cause short-term 
tolerance to effects of endotoxins, this might obscure the actual dose-effect re-
lationship, as might also the “healthy worker effect” in Rylander’s study. Finally, 
it cannot be ruled out that other constituents of cotton dust may also be of im-
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portance in the development of acute pulmonary effects. This was suggested by 
the results of a study performed by Buck et al, 1986, in which changes in lung 
function were demonstrated when healthy volunteers were exposed to an endo-
toxin-free eluate of cotton dust (11). 
In a study performed in an experimental cardroom, Haglind and Rylander, 
1984, demonstrated that a dose-related decrease in FEV1 was more pronounced  
in smoking cotton mill workers (n = 4) resulting in a threshold of 80 ng/m
3
 versus 
170 ng/m
3
 in non-smoking (n = 13) volunteers (39). This suggests an increased 
risk for smokers. 
Endotoxin-related acute lung function changes as reported in the above 
summarised experimental studies have been confirmed in the following two 
observational studies (21, 86, 88).  
Donham et al, 1989, found a relationship between endotoxin exposure and an 
across-shift decrement of FEV1 and the maximal expiratory flow rate at 25 % of 
FVC (MEF25, same as FEF75) in 41 non-smoking swine confinement workers. The 
mean 2–8 hour endotoxin exposure, characterised by area sampling of total dust, 
was 180 ng/m
3
 (1 800 EU/m
3
). By regression analysis, it was estimated that de-
crements in FEV1 over a workshift began at 180 ng/m
3
 (21). 
Milton et al, 1995 and 1996, showed a dose-effect relationship with across- 
shift changes over 4 hours in self-recorded peak expiratory flow (PEF) of 37 fibre-
glass workers exposed to 0.4–759 ng/m3 (4–7 590 EU/m3) of endotoxins (personal 
sampling). An effect on across-shift changes in FEV1 was also suggested but was 
not as strong as that demonstrated for PEF. In the medium exposure group (geo-
metric mean 8.4 ng/m
3
, range 4–15 (84 EU/m3, range 40–150)), a ≥ 5 % decline in 
PEF was observed. Therefore, the authors defined 8.4 ng/m
3
 as the lowest adverse 
observed effect level (LOAEL) and 1.7 ng/m
3
 as the NOAEL (86, 88). 
Later data 
Later studies are described below and those showing dose-effect relationships are 
also summarised in Table 5 (except the challenge study).  
In a study from 1999 by Kline et al, 72 healthy volunteers (non-atopic, non-
asthmatic, non-smoking) were exposed (within several hours) in sequence to in-
creasing single doses of nebulised LPS: 0.5, 1.0, 2.0, 3.0, 5.0, 10 and 20 μg LPS/ 
person by inhalation challenge. Lung function was examined 1, 10, 20 and 30 
minutes after inhalation of each dose. The inhalation challenge was continued 
with the next dose of LPS if the FEV1 decrease of the subject was less than 20 % 
30 minutes after exposure. Marked differences in the response to inhaled LPS 
were observed. Eight “sensitive” subjects had at least a 20 % decline in FEV1 after 
inhaling 6.5 μg LPS or less per person (cumulative dose). Eleven “hyposensitive” 
persons maintained an FEV1 > 90 % after inhaling 41.5 μg LPS/person. The three 
most sensitive responders reached an FEV1 decrease of 20 % at the second dose 
(1.5 μg LPS/person, cumulative dose) (61). 
Donham et al, 2000, studied poultry workers (n = 257) and found a statistically 
significant dose-effect relation between lung function decrement (FEV1 and 
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forced expiratory flow at 25–75 % of lung volume (FEF25–75)) over a workshift 
(2–4 hours) and each quartile of exposure to endotoxins and dust levels (both total 
and respirable fraction). The exposure-effect correlations were weak with cor-
relation coefficients (r) of 0.16 (r
2
 = 0.026) and 0.19 (r
2
 = 0.036) for respirable and 
total endotoxins, respectively. These low coefficients indicate that only 3–4 % of 
the variation in lung function is explained by endotoxin exposure. This is explained 
by the relatively small changes over the workshift relative to the measurement error 
of 1–3 % for an individual lung function measurement. Correlation and multiple 
regression were used to calculate the levels at which a 3 % across-shift change in 
FEV1 was statistically significant. This was the case at concentrations of 2.4 mg/m
3
 
total dust, 0.16 mg/m
3
 respirable dust, 614 EU/m
3
 (61.4 ng/m
3
) endotoxins and 
0.35 EU/m
3
 (0.035 ng/m
3
) respirable endotoxins. The combination of 614 EU/m
3
 
endotoxins and 0.35 EU/m
3
 respirable endotoxins is remarkable, as 3.7 % of total 
endotoxins was respirable. This might, however, be due to division of individual 
exposure in four groups, each containing a quartile of the exposure level. For each 
quartile, the odds ratio (OR) and its 95 % confidence interval (CI) for 3 % ΔFEV1 
was calculated. If the OR was significantly different from 1, the lower limit of the 
group was proposed as no effect level. The relatively arbitrary NOAELs in com-
bination with weak correlations limit the usefulness of this study (22).  
In 25 organic waste collectors, FEV1 was significantly reduced on Thursday 
pre-shift as compared to Monday pre-shift. Personal full-shift measurements re-
vealed endotoxin levels in the range 7–180 EU/m3 with an arithmetic mean of 31 
and a median of 13 EU/m
3
. There was also co-exposure to bacteria (1.2 × 10
6
/m
3
) 
and fungal spores (4 × 10
5
/m
3
) (47).  
Bønløkke et al, 2009, investigated the health effects in swine farm workers 
during summer and winter. Twenty-four workers underwent lung function testing 
and blood sampling before and after work. The mean endotoxin exposure of  
the workers was highest during winter (25 690 vs. 6 553 EU/m
3
during summer,  
p = 0.004). Although exposure to endotoxins varied between the seasons, no 
differences in lung function were found between the seasons (12). Earlier results 
also showed seasonal differences in endotoxin levels in pig houses (100) and in 
intensive livestock production (111). On the other hand, Seedorf et al did not 
observe a significant seasonal variation in airborne endotoxin concentrations in 
livestock buildings (cattle, pigs and poultry) (112). 
Dosman et al, 2006, investigated if inflammatory response can be predicted by 
FEV1 response following swine barn exposure. Twenty naïve males were exposed 
at baseline, low (452 EU/m
3
) and high (3 984 EU/m
3
) swine dust levels for 5 
hours. There appeared to be a dose-effect relationship between the endotoxin 
levels and lung function decrements. However, no formal statistical testing was 
presented. The subjects were classified as more or less responsive based on a re-
duction in FEV1 over a workshift following the high swine dust exposure. High 
responders also had significantly greater across-shift FEV1 reductions at the low 
exposure level (23). 
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Table 5. Effects on lung function after acute and short-term endotoxin exposure.  
Study design and population Exposure 
source 
Endotoxin exposure 
mean (range) 
Effects reported
 
 Reference 
Experimental exposure (6 h) of healthy 
volunteers, pre-selected for being reactive  
to endotoxin, n = 33–61 
Cotton 6–779 ng/m3  
(60–7 790 EU/m3) 
(108 sessions) 
Linear regression: 0 % across-shift change in FEV1 at 
9 ng/m
3
 (90 EU/m
3
). 
(13) 
 
Experimental exposure (4 h) of cotton mill 
workers, n = 15, of which 8 had a history of 
byssinosis 
Cotton 70–5 620 ng/m3  
(700–56 200 EU/m3) 
Linear regression: 0 % across-shift change in FEV1 at  
33 ng/m
3
 (330 EU/m
3
). 
(109) 
 
Experimental exposure (4 h) of:  
- non-smoking volunteers, n =13 and  
- smoking cotton mill workers, n = 4 
Washed 
cotton 
80–1 206 ng/m3  
(80–12 060 EU/m3) 
Linear regression: 0 % across-shift change in FEV1 at  
170 ng/m
3
 (1 700 EU/m
3
) in the volunteers and  
80 ng/m
3
 (800 EU/m
3
) in cotton mill workers. 
(39) 
 
Experimental exposure (5 h), non-smoking 
male volunteers, n = 20 
Swine  
dust 
a
 
baseline,  
low (452 ± 66 EU/m
3
) and  
high exposure (3 984 ± 498 
EU/m
3
) 
There appeared to be a dose-related decline in across-shift 
FEV1, however, no formal statistical test data were pre-
sented. Two groups of responders appeared (low and high) 
after both exposures.  
(23) 
 
Observational study in non-smoking swine 
farm workers exposed 2–8 h, n = 41 
Swine  
dust 
a
 
180 (4–330) ng/m3 
(1 800 (40–3 300 EU/m3)) 
Across-shift decline in FEV1 appeared at 180 ng/m
3
 (1 800 
EU/m
3
). 
(21) 
 
Observational study in waste handlers, n = 25 Org. waste 
b
 31 (7–180) EU/m3 FEV1 decline of 120 ml from Monday to Thursday morning. (47) 
Observational study in poultry workers 
exposed 2–4 h, n = 257 
Poultry 
faeces  
and feed 
a
 
0.24–39 167 EU/m3 
(2.4–3 917 ng/m3) 
mean ± SD:  
1 589 ± 3 394 EU/m
3 
(159 ± 339 ng/m
3
) 
> 3 % across-shift decline in FEV1 at > 61.4 ng/m
3
  
(614 EU/m
3
). 
(22) 
 
Observational study in glass wool 
manufacturers exposed 4 h, n = 37 
Recycled 
wash water 
0.4–759 ng/m3  
(4–7 590 EU/m3) 
≥ 5 % across-shift decline in self-recorded PEF at 8.4 ng/m3 
(84 EU/m
3
). No significant changes in across-shift FEV1. 
No effects observed at 1.7 ng/m
3
 (17 EU/m
3
). 
(86, 88) 
 
a 
Co-exposure to e.g. ammonia, 
b
 Co-exposure to bacteria and fungal spores. 
EU: endotoxin unit, FEV1: forced expiratory volume in 1 second, PEF: peak expiratory flow, SD: standard deviation.  
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7.3 Long-term exposure 
7.3.1 Effects on lung function and respiratory symptoms 
Health Council report, 1998  
Studies on long-term effects described in the previous Health Council report (41) 
that yielded dose-effect relationships are described below and in Table 6. 
Kennedy et al, 1987, performed a cross-sectional study investigating the re-
lationship between endotoxin and dust exposure and lung disease in 443 cotton 
workers from Shanghai, China and 439 control subjects from a silk mill nearby 
(57). Pre- and post-shift FVC and FEV1 were determined for each worker. In  
130 area samples (aerodynamic diameter < 15 μm), the endotoxin concentrations 
varied from 1 to 920 ng/m
3
 (10–9 200 EU/m3) and dust concentrations varied 
from 0.15 to 2.5 mg/m
3
. The cotton worker population was stratified by current 
endotoxin exposure into four groups with median endotoxin exposures of 2, 100, 
230 and 520 ng/m
3
 (20, 1 000, 2 300 and 5 200 EU/m
3
). Groups were then com-
pared for FEV1, FVC, FEV1/FVC %, across-shift ΔFEV1 and prevalences of 
chronic bronchitis and byssinosis. All analyses were adjusted for confounders such 
as age, height and smoking habits. Dose-effect/dose-response trends were seen for 
the current endotoxin level and FEV1, ΔFEV1, and prevalence of chronic bronchitis 
and byssinosis, except for the highest exposed group in which a reversal of the 
trend was seen, most likely to be caused by a “healthy workers effect”. The dose-
effect relation for current exposure was statistically significant for measured pre-
shift FEV1 and was calculated to be -0.242 ml per ng/m
3
 (or per 10 EU/m
3
) (p < 
0.10), or, when the highest endotoxin exposure category was excluded, the co-
efficient increased to -0.778 ml per ng/m
3
 (or per 10 EU/m
3
) (p < 0.01) for workers 
with a mean work history of 15 years. No correlation coefficient was given. Mean 
pre-shift FEV1 in group 1 (median 2 ng/m
3
) and group 2 (median 100 ng/m
3
) were 
higher than that in the control group of silk workers (FEV1 set on 100 %). FEV1 in 
group 3 (median 230 ng/m
3
) was 96.7 % and in group 4 (median 520 ng/m
3
) 98.5 
% for non-smokers (both not statistically significantly different from the control 
group) (57). The authors attempted to assess the presence of a threshold level of 
endotoxin exposure by comparing the silk workers (controls) to the cotton workers 
who had always worked in an area with “low endotoxin” levels (less than 20 ng/m3 
or 200 EU/m
3
). They found no difference in baseline (= pre-shift) spirometry, but 
based on the increased prevalence of byssinosis and chronic bronchitis and the 
augmented across-shift change in FEV1, the authors suggested that even exposure 
to the lowest level of endotoxins at 1–20 ng/m3 (10–200 EU/m3) constitutes an 
“adverse respiratory health effect” (57). 
Smid et al, 1992, performed a similar cross-sectional study in 315 subjects 
working in 14 animal feed mills in the Netherlands (120). The average 8-hour 
personal inhalable dust (< 30 μm) exposure was 9 mg/m3 (range 0.2–150) grain 
dust and 25 ng/m
3
 (range 0.2–470) (250 EU/m3) endotoxins based on 530 personal 
dust samples. An external control group was selected without exposure to agents 
that may affect the respiratory system. This group was, however, not used in the 
epidemiological analyses as they differed with respect to variables other than 
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exposure. Further analyses were then performed only with exposed workers and 
internal control subjects who consisted of non-production animal feed workers. 
Analyses were adjusted for confounders such as age, height and smoking habits. 
All studied lung function variables (FVC, FEV1, PEF, maximal expiratory flow 
rate at 75 % and 50 % of FVC (MEF75 and MEF50)) showed significantly reduced 
values with increasing current exposure to both dust and endotoxins. The dif-
ferences between the endotoxin categories appeared to be somewhat greater than 
those between the dust categories. The stronger relationship for endotoxins was 
also indicated by similar or lower p-values than those for dust exposure. Mean 
current exposure levels per job title ranged from 6 to 68 ng/m
3
 (60–680 EU/m3) 
for endotoxins and from 1.7 to 29.7 mg/m
3
 for dust. The dose-effect relation for 
current endotoxin exposure and FEV1 was calculated to be -4.91 ml per ng/m
3
 (or 
per 10 EU/m
3
) for workers with a mean work history of 13 years (annual FEV1 
change -0.38 ml per ng/m
3
 based on present exposure and -0.34 ml per ng/m
3
 
based on cumulative exposure). No clear differences in symptom prevalences 
existed between different exposure groups. The estimated cumulative exposures 
of both dust and endotoxins were significantly related to lung function impair-
ment (120). 
In 1993, Smid calculated a safe threshold level based on the studies on animal 
feed workers. Both acute and chronic lung function effects were demonstrated in 
the intermediate exposure group (40 ng/m
3
 or 400 EU/m
3
) as compared to the low 
exposure group (< 15 ng/m
3
 or < 150 EU/m
3
). The upper limit of the lower ex-
posure group was chosen as the LOAEL. It was estimated from regression models 
that 40 years of exposure to 15 ng/m
3
 (150 EU/m
3
) may lead to a decrease in FEV1 
of approximately 200 ml (which is equivalent to approximately 5 %). For MEF75, 
the effect would be 1 200 ml/second (approximately 16 %). Thus, the author 
suggested that the NOAEL would be below 15 ng/m
3
 (150 EU/m
3
). Taking into 
account selection and attenuation leading to downward bias, the author applied a 
safety factor to the LOAEL and proposed a “safe” level between 3 and 7.5 ng/m3 
(30–75 EU/m3) (119), as cited in (41). 
Later data 
Later studies concerning effects on lung function after long-term exposure are 
presented in Table 6. For studies in which dose-relationships were examined, a 
more detailed description follows below. 
Post et al, 1998, followed up 140 workers in the grain processing and animal 
feed industry for 5 years (98). This study was a follow-up of the study population 
of the previously described cross-sectional study by Smid et al, 1992 (120). During 
the first survey, 520 personal exposure samples were gathered (120), and another 
179 samples were gathered during the second survey. Mean exposures per job title 
ranged from 3.6 to 99 ng/m
3
 (36–990 EU/m3) for endotoxins. FEV1 and maximal 
midexpiratory flow (MMEF, the average expiratory flow over the middle half of 
the FVC) were measured on Mondays at the beginning of the study and app-
roximately 5 years later. The annual decline in FEV1 and MMEF (both corrected 
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for age, height and smoking) were statistically significantly related to occupational 
exposure to dust and to endotoxins. An FEV1 decrease of 0.33 ml (standard error, 
SE = 0.14) (0.0077 % ± 0.0033) per ng/m
3
 endotoxins (or 10 EU/m
3
) per year of 
exposure (r
2
 = 0.12) was calculated. Fourteen percent of the workers had a rapid  
(> 90 ml/ year) annual decrease in FEV1 during the 5 years of the study. Workers 
with an endotoxin concentration > 20 ng/m
3
 (200 EU/m
3
) had a statistically sig-
nificantly higher risk (OR 3.3, 95 % CI 1.02–10.3) of rapid decline in FEV1. In-
creasing working years was related to decreasing annual decline in FEV1 (-18 ml) 
for over 20 working years and to fewer people with rapid decline in FEV1. 
Christiani et al, 1999, performed an 11-year follow-up study in cotton (n = 349) 
and silk workers (n = 319, both active and retired) recruited in Shanghai, China 
(17) (same cohort as in the study by Kennedy et al (57)). Mean exposure per work 
area (area sampling) of the cotton workers ranged from 0.2 to 1.6 mg/m
3
 for dust 
and was 42–12 038 EU/m3 (4.2–1 204 ng/m3, mean approximately 1 500 ± 1 900 
EU/m
3
 or 150 ± 190 ng/m
3
) for endotoxins, compared to a mean of 0.2 mg/m
3
 dust 
and no (< 1 EU/m
3
) endotoxins for silk workers (17). At the beginning of the 
study, respiratory symptoms occurred more often in cotton workers than in silk 
workers; byssinosis and chest tightness at work (both 8 % in cotton workers vs.  
0–0.2 % in silk workers); chronic bronchitis (22 % vs. 8 %); chronic cough (20 % 
vs. 7 %) and dyspnoea (grade 2 +) (15 % vs. 4 %) (16). A total of 730 air samples 
were collected over the 11-year survey period. Mean years of employment at the 
end of the study were 25 years. The average annual FEV1 loss was the same for 
cotton and silk workers. Though initially the FEV1 loss in cotton workers was 
(statistically non-significantly) higher with 40 ml/year compared to 30 ml/year in 
silk workers, after 5 years of follow up, the FEV1 loss in the last 6 years of study 
was only 18 ml/year in cotton workers compared to 27 ml/year in silk workers. 
The total FEV1 decrease in 11 years was 0.31 litres in both cotton and silk workers 
and FEV1 values were 100 % (of predicted) in cotton and silk workers both at base-
line in 1981 (99.6 % cotton and 100.6 % silk), as well as 11 years later in 1992 
(100.0 % and 100.3 %). After adjustment for confounders, the 11-year loss in 
FEV1 was associated with cumulative dust but not with endotoxin exposure (17). 
In 2001, Christiani et al published the results of another 4-year follow-up, in 
total 15 years (same cohort). A total of 802 air samples were collected over the 
15-year survey period, the medium cumulative endotoxin exposure was 48 000 
EU/m
3
 × years (4 800 ng/m
3
 × years). A small but statistically significantly higher 
annual FEV1 loss was found in cotton workers (-32.3 ± 1.0 ml, or 1.1 %) compared 
to silk workers (-29.4 ± 1.0 ml or 1.0 %) (16). However, the annual decrease in 
FEV1 in this study was rather similar to that found in the previous study, and the 
FEV1 remained 100 % of the predicted value. It can therefore be assumed that de-
spite the significantly higher decrease in FEV1 in cotton workers, the FEV1 will 
still not be significantly lower than 100 % of predicted. The difference was found 
only in smokers, as non-smokers had similar annual FEV1 losses in both groups. 
A statistically significant relation was found between the annual change in FEV1 
and the across-shift change in FEV1 (ΔFEV1). An acute FEV1 change of -1 % was 
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associated with an average annual decline in FEV1 of 0.061 % (p < 0.001, r
2
 not 
given). A statistically significant relation of accelerated chronic loss in FEV1 to 
byssinosis or chest tightness at work was observed. 
In 2005, Wang et al published a 20-year follow-up of the same cohort and also 
presented results from the previous surveys. The cohort now consisted of 346 
cotton and 342 silk textile workers. Cotton workers had a mean cumulative endo-
toxin exposure of 49 123 (± 45 284) EU/m
3
 × year. The cotton workers had a 
greater annual decline in FEV1 (32.4 ± 1.0 ml/year) compared to the silk workers 
(27.3 ± 0.9 ml/year) (135). 
Kirychuk et al, 1998, studied 42 swine-confinement workers in a longitudinal 
study for 5 years. ΔFEV1, annual rate change in FEV1 and FVC, and only the re-
spirable fraction of personal endotoxin exposure were measured at baseline and 
after 5 years. The mean exposure to respirable endotoxins was about 65 EU/m
3
 
(6.5 ng/m
3
). The mean annual rate change between baseline and follow-up for 
FEV1 was -54 ± 62 ml/year (-1.2 ± 1.4 %) and for FVC -49 ± 72 ml/year (-0.9 ± 1.3 
%) (60). No statistically significant relation was found between annual FEV1 or 
FVC decrease and airborne respirable endotoxins, probably due to the low number 
of workers studied (resulting in a low power). Therefore, the committees consider 
the use of this study limited. Furthermore, the committees noted that the authors 
incorrectly adjusted the calculation for the initial FEV1 level. 
Laitinen et al, 2001, assessed associations between self-reported symptoms and 
exposure to endotoxins of workers in several industries. Among 77 workers, the 
number of workers with respiratory complaints or fever/shivering was statistically 
significantly higher when the concentration of biologically active endotoxins in 
the air was over 25 ng/m
3
 (250 EU/m
3
). Reporting of eye symptoms and chest 
tightness was higher when the airborne concentration of biologically active endo-
toxins was over 150 ng/m
3 
(1 500 EU/m
3
). Excluding workers with atopy or 
symptoms of chronic bronchitis from the analysis did not change the results (64). 
Division of exposed workers into 2 groups (below or above 25 and 150 ng/m
3
 
(250 and 1 500 EU/m
3
), respectively) seemed arbitrary as no statements were 
made about the origin of these limits. 
In 2004, Latza et al performed a cross-sectional study in 114 male employees of 
a cotton mill in western Germany. Airborne endotoxin exposures were classified 
as low (< 100 EU/m
3
), medium (100–450 EU/m3) or high (> 450 EU/m3). The 
dose-response relationships between endotoxin exposure and prevalences of 
wheezing (medium exposure group: OR 2.15, 95 % CI 0.48–9.62; high exposure 
group: OR 5.49, 95 % CI 1.17–25.81) and cough (medium exposure group: OR 
2.11, 95 % CI 0.59–7.56; high exposure group: OR 3.93, 95 % CI 1.02–15.12) 
during the last 12 months were significant for the highest exposure group (> 450 
EU/m
3
) (69). 
In 2007, Oldenburg et al performed a cross-sectional study in which 150 em-
ployees (114 male and 36 female) of the same German cotton spinning mill under-
went lung function testing. Airborne endotoxin exposures were classified as low 
(< 100 EU/m
3
), medium (100–450 EU/m3) and high (> 450 EU/m3). The dose-
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response relationship between current endotoxin exposure and prevalence of an 
obstructive ventilation pattern was significant (OR 11.2, 95 % CI 1.03–121.2 for 
the highest exposure group). No significant deviation was observed in mean lung 
function parameters in the different exposure groups (94). 
In a large study of Simpson et al, 1998, prevalence of symptoms and endo- 
toxin exposure levels were measured for 1 032 workers in several occupations  
and industries. Lower respiratory tract symptoms recorded were cough, phlegm, 
shortness of breath, wheeze and chest tightness. ODTS was identified in people 
reporting recurrent episodes of at least two of the following symptoms: fever, 
shivering, malaise, weakness and joint or muscle pain. Byssinosis, work-related 
chronic bronchitis and eye and nasal irritation were also registered. A relation 
between prevalence of symptoms and endotoxin exposure levels was shown (115). 
The authors showed a figure with percentage of workers with lower respiratory 
tract symptoms plotted against the mean endotoxin level for that group of workers, 
and a log-linear regression line was drawn. However, the plotted data indicated 
that an exponential curve would give a better fit and that symptoms were noticeably 
increased at endotoxin levels above approximately 50 ng/m
3
 (500 EU/m
3
). How-
ever, as raw data were not available, no calculations could be performed and no 
quantitative conclusions can be drawn. The study showed that workers with 
symptoms had consistently higher exposures to dust and endotoxins compared to 
their counterparts working in the same occupations, though the difference was not 
statistically significant. Highest prevalences of lower respiratory tract symptoms 
and nasal and eye symptoms were found in poultry workers. Despite high levels 
of exposure to endotoxins (up to 50 μg/m3 (500 000 EU/m3)) only 1.3 % of all 
workers suffered from ODTS (115). 
Vogelzang et al, 1998, performed a 3-year follow-up study in 171 pig farmers. 
Those were selected out of a larger group of pig farmers in a way that half the 
farmers included in the study would be symptomatic. The mean endotoxin con-
centration was 105 ng/m
3
 (1 050 EU/m
3
). A decrease in baseline FEV1 of 73 ml/ 
year (compared to a normal age-related decrease of 29 ml/year) and a decrease in 
FVC of 55 ml/year were found (138). In an additional paper, bronchial responsive-
ness was measured. Provocative histamine concentrations (PCs) were measured 
for 10 % and 20 % FEV1 falls. PC10 and PC20 decreased in both symptomatic and 
asymptomatic groups within 3 years of additional exposure to ammonia and dust 
(137). 
Smit et al, 2008, conducted a cross-sectional study in 877 Dutch farmers and 
agricultural industry workers in 2006. They investigated exposure-response re-
lationships between current endotoxin exposure and allergic and respiratory 
symptoms in adults, taking into account farming exposures during childhood. 
Based on 249 full-shift personal airborne endotoxin samples, a job-exposure 
matrix was constructed to assign endotoxin exposure levels to all participants. 
Associations between endotoxin exposure and questionnaire data on symptoms 
were studied by multiple logistic regressions. Adjusted ORs for an interquartile  
range increase in endotoxin levels were elevated for respiratory symptoms such   
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Table 6. Effects on lung function after long-term occupational endotoxin exposure.  
Study design and  
population 
Control 
population 
Work 
history
 a
 
Endotoxin exposure 
mean (range) 
Parameters  
measured 
Effects reported Reference 
Cross-sectional, 
animal feed workers,  
n = 265 
Non-
exposed 
colleagues 
n = 50 
13 yrs < 15, 30–40 and 67 ng/m3  
(range 0.2–470 ng/m3)  
(< 150, 300–400 and 670 EU/m3) 
Stratified exposure-
response analyses for 
FEV1 and respiratory 
symptoms 
Regression
 b
: annual FEV1 change =  
-0.34 ml per ng/m
3
 or per 10 EU/m
3
. 
(120) 
 
5-year follow-up,  
grain and animal feed 
industry workers, n = 140 
(same cohort as above) 
No 12.5 ± 
8 yrs 
3.6–99 ng/m3  
(36–990 EU/m3) 
Annual decline in 
FEV1, FVC, MMEF, 
PEF, MEF25, MEF50, 
MEF75 (over 5 yrs) 
Regression
 b
: annual FEV1 change =  
-0.33 ml (SE = 0.14, r
2
 = 0.12) per ng/m
3
  
or per 10 EU/m
3
. 
(98) 
 
Cross-sectional, 
cotton mill workers, 
 n = 443 
Silk 
workers 
n = 439 
16–17 
yrs 
2, 100, 230 and 520 ng/m
3
  
(20, 1 000, 2 300 and 5 200 EU/m
3
) 
Stratified exposure-
response analyses for 
FEV1 and respiratory 
symptoms 
Regression
 b
: annual FEV1 change =  
-0.016 to -0.052 ml per ng/m
3
 or per 10 EU/m
3
.
c
 
(57) 
 
11-year follow-up, 
employed and retired  
cotton workers, n = 349 
(same cohort as above) 
Silk 
workers 
n = 319 
16–17 
yrs 
≈ 40 000 d EU/m3× yr (cumulative)  
1 500 (27–12 038) EU/m3  
(150 ng/m
3
)  
Annual FEV1 loss No cumulative endotoxin effects on FEV1. (17) 
 
15-year follow-up, 
employed and retired  
cotton workers, n = 346 
(same cohort as above) 
Silk 
workers 
n = 338 
16–17 
yrs 
48 000 EU/m
3
× yr (median 
cumulative)  
1 500 EU/m
3
 (150 ng/m
3
) 
Annual FEV1 loss Greater annual FEV1 decline as compared to 
controls (1.1 % per yr vs. 1.0 %); correlation 
between ΔFEV1 and annual FEV1 decline. 
Findings independent from endotoxin exposure. 
(16) 
 
20-year follow-up, 
employed and retired  
cotton workers, n = 346 
(same cohort as above) 
Silk 
workers 
n = 342 
16–17 
yrs 
49 000 EU/m
3
× yr Annual FEV1 loss Greater annual FEV1 decline (32.4  ± 1.0 ml/yr) 
as compared to controls (27.3  ± 0.9 ml/yr).  
(135) 
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Table 6. Effects on lung function after long-term occupational endotoxin exposure.  
Study design and  
population 
Control 
population 
Work 
history
 a
 
Endotoxin exposure 
mean (range) 
Parameters  
measured 
Effects reported Reference 
9-year follow-up, 
RDF workers with 
rotating jobs, n = 87 
No 9–10 
yrs 
Geometric mean:  
28 ± 3.8 EU/m
3
 
(2.8 ± 0.38 ng/m
3
) 
FVC and FEV1 
change over 9 yrs 
No effect observed. (76) 
 
Cross-sectional, 
pig farmers of which 50 % 
symptomatic, n = 40  
poultry farmers of which  
58 % symptomatic, n = 36 
General 
population 
20 yrs Median (range): 
58 (1–1 101) ng/m3 
(580 EU/m
3
) 
258 (19–1 635) ng/m3 
(2 580 EU/m
3
) 
FEV1, MMEF and 
FVC 
% predicted FEV1: > 100 % in both groups. 
% predicted MMEF: 101 % in pig farmers. 
   89 % in poultry farmers. 
(102) 
 
Longitudinal, 
cotton workers in 3 mills, 
newly hired young 
(average 18 yrs) non-
smoking females, n = 101 
No 0.0 yrs 220, 1 360 and 1 070 ng/m
3
  
(2 200, 13 600 and 10 700 EU/m
3
) 
at 3 months 
Change in FEV1, 
FVC and ΔFEV1 
after 3, 12, 18 months 
as compared to 1st 
day of work 
FEV1 and FVC: 2 % ↑ after 3 months. 
FVC: 5 % ↓ after 12 and 18 months.  
FEV1: 2.8 % ↓ after 12 months and 1.3 % ↓  
after 18 months. 
(134) 
 
3-year follow-up, 
pig farmers selected so 
that 50 % had symptoms,  
n = 171 
No 16.7 
yrs 
105 ng/m
3
 (1 050 EU/m
3
) FEV1 and FVC Decrease in baseline FEV1 of 73 ml/yr  
and a decrease in FVC of 55 ml/yr. 
(137, 138) 
 
11-year follow-up, 
paper workers (males 
employed 1989–2000),  
n = 97 
n = 55 - 69 (6–370) EU/m3 ΔFEV1 and ΔFVC 
yearly for 11 yrs 
No increase in loss of lung function in workers 
exposed up to 200 EU/m
3
. 
(113) 
 
Cross-sectional, 
paper workers (bark 
cleaning and paper 
recycling in paper 
factory), n = 77 
Office 
workers 
n = 40 
12 yrs Low-exposure group: 
2–20 ng/m3 (20–200 EU/m3) 
High-exposure group:  
21–98 ng/m3 (210–980 EU/m3) 
Serum MPO and 
ECP, airway 
responsiveness, 
symptoms and 
baseline FEV1 
Decreased baseline FEV1, increased airway 
responsiveness, elevated serum MPO and ECP 
levels and nose irritation in both groups. Flu-
like symptoms in the high-exposure group.  
(110) 
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Table 6. Effects on lung function after long-term occupational endotoxin exposure.  
Study design and  
population 
Control 
population 
Work 
history
 a
 
Endotoxin exposure 
mean (range) 
Parameters  
measured 
Effects reported Reference 
Cross-sectional,  
veterinarians, non-
smoking and without 
asthma, n = 66 
General 
population 
nd 2.8–3.6 hours/day: 
18–28 ng/m3 (180–280 EU/m3)  
8-hour TWA: 
9 ng/m
3
 (90 EU/m
3
) 
% of subjects  
with diurnal PEF 
variation > 20 % 
No effects observed. (31) 
a 
At the start date of the study.  
b 
Linear regression: annual ΔFEV1 = β × endotoxin exposure (ng/m
3
 or EU/m
3
). 
c 
For comparability with other studies, -0.242 to -0.778 ml FEV1 change per ng/m
3
 over 15 years has been converted to annual FEV1 change. 
d
 Calculated by NEG from a cumulative mean exposure of 23 826 EU/m
3
× yr at baseline and an estimated annual exposure of ca. 1 500 EU/m
3
 for 11 years. 
ECP: eosinophilic cationic protein, EU: endotoxin unit, FEV1: forced expiratory volume in 1 second, FVC: forced vital capacity, MEFx: maximal expiratory flow rate at x % 
of FVC, MMEF: maximal midexpiratory flow (average flow over middle half of FVC), MPO: myeloperoxidase, nd: not determined, PEF: peak expiratory flow, RDF: refuse-
derived fuel, SE: standard error, TWA: time-weighted average. 
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as wheezing (OR 1.41, 95 % CI 1.16–1.72), wheezing with shortness of breath 
(OR 1.50, 95 % CI 1.18–1.90) and daily cough (OR 1.29, 95 % CI 1.03–1.62). In 
contrast, endotoxin exposure was strongly associated with a decreased prevalence 
of hay fever (OR 0.62, 95 % CI 0.49–0.78). Workers who had grown up on a farm 
had a lower prevalence of hay fever, but no evidence was found of effects modi-
fication by farm childhood. Smit et al concluded that occupational endotoxin ex-
posure in adulthood was associated with an increased risk of asthma-like symptoms 
but a reduced prevalence of hay fever (121).  
7.4 Carcinogenicity 
Cancer risks have been investigated in relation to occupational exposure to endo-
toxins. In the 1970s, findings in several occupational cohort studies suggested 
reduced risks in mortality studies for lung cancer among textile workers (48, 50, 
66, 79). More recent findings suggest an inverse dose-response for lung cancer. 
Astrakianakis et al, 2007, observed a dose-dependent reduction in lung cancer 
risk in a cohort of female textile workers in Shanghai (4). The authors stated that 
the study had several limitations. A potential source of bias is the “healthy worker 
effect”. However, the authors concluded that a healthy worker effect was probably 
not an important bias in their study. Only limited epidemiological evidence for 
this relation is available in other industries with endotoxin exposure. 
In a recent review concerning the relation between exposure to endotoxins and 
cancer, Lundin et al concluded that epidemiological studies of cotton textile and 
other endotoxin exposed occupational groups have consistently demonstrated 
reduced lung cancer risks. However, absence of data on potentially confounding 
factors has been a limitation of most studies (74). 
7.5 Reproductive effects 
There were no data available. 
7.6 Immunological effects 
CD14 is a regulator of T-cell activity, which may have great relevance to the 
pathogenesis of allergic asthma. The ligation of endotoxin to CD14 depends on 
the presence of a transporter protein, the LPS binding protein. The LPS binding 
protein is an acute-phase protein that circulates in plasma and binds to endotoxins 
forming high affinity complexes that enhance the capacity of low-concentrations 
of endotoxins to bind to and activate macrophages and neutrophils. Under normal 
conditions, little LPS binding protein is present in the lung. After inhalation of 
antigen by atopic subjects, extravasations of LPS binding protein and soluble CD14 
to this compartment occur, due to rapid increase in bronchial microvascular per-
meability. This allows the endotoxin that was inhaled with the antigen to amplify 
the inflammatory response to the antigen (80), while the other way round, the 
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simultaneous presence of antigens leads to an exaggerated response to endotoxins 
in asthmatic subjects (61). 
In a study performed by Michel et al, 1989, bronchial obstructive responses 
(associated with an increase in non-specific bronchial reactivity) were demon-
strated in asthmatic and rhinitis patients at an inhalatory dose of 20 μg endotoxins 
(LPS) (200 000 EU) per person, while no bronchial constriction at this level was 
observed in healthy subjects. Healthy subjects responded at a dose level of 200 μg 
(2 000 000 EU) endotoxin/person. No significant response was observed in the 
asthmatic and rhinitis patients at dose levels up to 2 μg (20 000 EU) endotoxin/ 
person. Endotoxin-induced bronchial obstruction was reflected in decreased forced 
expiratory values (e.g. FEV1) (83).  
Low levels of endotoxin exposure significantly augment the inflammatory 
response to allergen exposure in sensitised subjects with asthma (72, 103), in 
subjects with allergic rhinitis (33), and in skin test wheal-and-flare response to 
allergen (80). In metropolitan households, higher house dust endotoxin levels 
have been associated with increased asthma symptoms (84, 139). Higher house 
dust endotoxin levels are also associated with more wheezing symptoms in the 
first year of life (36). Possible explanations for this association of endotoxin 
exposure with increased asthma symptoms at any age include an adjuvant-like 
effect of endotoxin exposure on airway inflammation, increased susceptibility to 
viral respiratory tract infections caused by endotoxin exposure, and respiratory 
manifestations after endotoxin inhalation in normal and asthmatic subjects (32, 
33, 61, 62, 80, 139). Significant blood leukocytosis and neutrophilia were ob-
served 4–8 hours after inhalation of endotoxins in normal and asthmatic subjects. 
In in vitro studies, it is observed that small amounts of endotoxins (< 1 ng/ml) 
activate human airway macrophages, releasing several pro-inflammatory cyto-
kines (TNFα, IL-1, IL-6) and metabolites of arachidonic acid (80). The presence 
of LPS binding protein and the soluble fraction of CD14 receptor in the airways 
increases the macrophage activation by endotoxins (26). After inhalation of endo-
toxin-containing dust (6 hours), high concentrations of IL-1, IL-1 RA, IL-6, IL-8 
and TNFα, and their mRNA were measured in BAL (19) (as cited in (80)). Also 
after exposure to endotoxin containing swine dust for 3 hours, IL-8 was induced 
in BAL and NAL fluid of non-smoking subjects (68). Increased neutrophil recruit-
ment was also observed in BAL (51) (as cited in (26)). A significant increase in 
neutrophils in the induced sputum occurred in asthmatic subjects after inhalation 
of 5–60 μg (50 000–600 000 EU) endotoxin/person, which was also seen to a 
lesser extent in normal subjects exposed to endotoxins (84, 92, 130). The sputum 
concentrations of myeloperoxidase (MPO, from neutrophils), eosinophilic cationic 
protein (ECP) and TNFα rose significantly 6 hours after endotoxin inhalation.  
Some published data suggests that environmental endotoxins could be a syn-
ergistic factor on the amplitude of an immunoglobulin E (IgE) mediated response. 
Allergic asthmatics exposed to air with low levels of endotoxins (250 ng/m
3
 or 
2 500 EU/m
3
) for 4 hours before bronchial challenge with allergen show an in-
creased bronchial reactivity and antigen-induced airway eosinophilia. While de-
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toxified allergen extract results in bronchial eosinophil recruitment, endotoxin 
contamination (1 ng/ml) causes recruitment of neutrophils. In sensitised subjects, 
inhalation of allergen leads to airway plasma exudation including extravasations  
of soluble CD14 and LPS binding protein (81). Asthmatic subjects exposed to 
endotoxins show a significant decrease in lung function, reflected in a decreased 
FEV1 and FEV1/FVC ratio, and PEF (24, 33, 84, 92). The decrease in FEV1 and 
systemic response were smaller in atopic than in non-atopic subjects, suggesting a 
link between atopic status and endotoxin responsiveness (7, 81, 82).  
Besides exacerbation of the adverse effects of asthma on the lungs in adults, it 
is hypothesised that exposure to endotoxins early in life (no particular dose levels 
given) has a protective effect on the early allergic response and thus the early 
development of atopic (allergic) asthma (72). This is thought to be mediated by 
binding of endotoxin to innate immune cells, which are thereby stimulated to pro-
duce cytokines supportive of T-helper cell type 1 (Th1) development, i.e. IL-12 
and interferon-gamma (IFNγ) (72, 73). The induction of a Th1 response in early 
life, separate from serious infection, down-regulates Th2-type immune develop-
ment, which is relevant in preventing atopy and possibly atopic asthma (25, 73). 
Although the studies on the protective effect of endotoxins in early development 
of allergy in children gave more insight into the mode of action, it is not directly 
relevant to the occupational exposure of endotoxins and the possible adverse 
health effects in adults including asthmatic persons. 
Endotoxins also induce up-regulation of CD14 expression by macrophages  
(67, 128). The membrane bound CD14 is a multifunctional receptor constitutively 
expressed primarily on the surface of monocytes, macrophages and neutrophils 
and serves as a receptor for the LPS - LPS binding protein complex (5, 9). CD14 
participates in regulation of IL-8 and IL-6 release by bronchial epithelial cells 
(128). The soluble form of CD14 is abundant in serum and is apparently derived 
both from secretion of soluble CD14 and from enzymatically cleaved glycosyl-
phosphatidylinositol-anchored membrane-bound CD14 (2), suggesting that poly-
morphism in the CD14 gene promoter region could influence the differentiation  
of T-cells and the levels of serum IgE. In a large cohort of allergic and non-allergic 
children, two alleles were found. Children exhibiting the TT allele presented higher 
levels of circulating soluble CD14, and lower IgE and IL-4 levels (2). Those 
children appeared to benefit from the protective effect of higher levels of soluble 
CD14, which allows stronger stimulation of Th1 during bacterial infections of 
endotoxin exposure in early life, hereby reducing the chances of becoming atopic. 
As described before, there is evidence for increased allergic response after endo-
toxin exposure. Furthermore, an increased response to endotoxin exposure has 
been observed in patients with symptomatic atopy or allergic asthma. However, 
no support is found for the hypothesis that chronic inhalatory endotoxin exposure 
may non-specifically encourage sensitisation to antigens in man (adjuvant effect). 
On the other hand, there is growing compelling evidence that even endotoxin 
exposure at adult age protects against the development of atopic responses. This 
evidence comes from occupationally exposed work force based studies in farmers 
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(45) and from general population samples. Despite the increased response to 
endotoxins in symptomatic atopics, the attribution of atopy to the increased 
prevalence of respiratory symptoms in exposed workers is rather small. The 
positive association between endotoxin exposure and respiratory effects in non-
atopics therefore predominates. Finally, the role of confounding effects due to 
atopy might even underestimate the association between endotoxin exposure and 
respiratory effects as was probably the case in the study of Smit et al, 2008 (121).  
In 2009, Smit et al conducted a case-control analysis with unrelated subjects  
to investigate whether single nucleotide polymorphisms (SNPs) in CD14, TLR2, 
TLR4 and TLR9 genes were associated with asthma in adults. The role of atopy 
was evaluated by conducting separate analyses for atopic and non-atopic subjects. 
The authors concluded that TLR2 and CD14 single nucleotide polymorphisms 
were associated with asthma and atopic asthma, respectively. In addition, CD14, 
TLR2, TLR4 and TLR9 single nucleotide polymorphisms modified the association 
between country living and asthma (122). 
Atopic asthmatics are more sensitive to endotoxin exposure than healthy sub-
jects. A possible explanation for the enhanced sensitivity of atopic asthmatics 
might be the fact that soluble CD14 and LPS binding protein levels in the lungs 
are severely increased (26). LPS binding protein and soluble CD14 are normally 
present in human plasma in concentrations of 5–10 μg/ml (132) (as cited in (26)) 
and ~ 6 μg/ml (6) (as cited in (26)), respectively. Extravagation of LPS binding 
protein and soluble CD14 into the bronchoalveolar compartment after antigen 
inhalation, due to increase in bronchial microvascular permeability, might en-
hance the capacity of inhaled endotoxins to activate an inflammatory response. On 
the other hand, atopic, but asymptomatic, subjects may have a genetically lower 
response to LPS, e.g. by lower levels of expression of soluble CD14 (2), lower 
expression of TNFα (89) or lower expression of LPS binding protein. Because  
of the lower response of macrophages to endotoxins, lower levels of IL-12 did 
stimulate the Th2 cell expression when the immune system was developing (72), 
which stimulates B-cell production of IgE by IL-4. So, hyporesponsiveness to 
endotoxins might have caused the atopy.  
7.7 Other effects 
Sjögren et al, 2003, compared the occurrence of ischaemic heart disease (IHD) 
among male and female livestock and agricultural workers in Sweden. The IHD 
mortality among the livestock and agricultural workers was compared to that of 
gainfully employed men and women. The standardised mortality ratio (SMR)  
for livestock male workers was 1.06 (95 % CI 0.95–1.18) and for female workers  
1.10 (95 % CI 0.98–1.23). Agricultural workers had lower SMRs. Adjustments for 
smoking habits increased the SMR by about 9 % in male workers and about 5 %  
in female workers (118). 
No data were available regarding neurological and endocrine effects. 
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7.8 Summary and evaluation 
Acute and short-term exposure 
Acute health effects in humans after inhalation of endotoxins are dry cough and 
shortness of breath accompanied by a decrease in lung function, fever reactions 
and malaise, and sometimes dyspnoea, headache and joint aches occurring a few 
hours after the exposure. Acute effects have been demonstrated in laboratory 
studies with human volunteers and in epidemiological studies in exposed workers. 
In a number of studies performed in volunteers and in workers, biological re-
sponses (not necessarily reflecting clinically manifest effects) were measured. In 
one study, the first responders in a group of healthy volunteers showed a ΔFEV1 
decline of at least 20 % after exposure to 1.5 μg (15 000 EU) (3 × 0.5 μg) endo-
toxin, whereas exposure to 0.5 μg (5 000 EU) did not lead to significant decline in 
ΔFEV1 in any of them (61).  
In another study, a clear exposure-effect relationship (% ΔFEV1 = 3.84 - 4.02 
(
10
log endotoxin in ng/m
3
) with an r
2
 = 0.72 and p < 0.0001) was found in a group 
of healthy volunteers (smoking and non-smoking) who were exposed to endotoxin 
concentrations up to 779 ng/m
3
 (7 790 EU/m
3
) for 6 hours. The linear regression 
model yielded a zero percentage across-shift change in FEV1 during exposure  
to endotoxins at 9 ng/m
3
 (90 EU/m
3
) (13). In a study of fibre-glass workers, an 
across-shift decline over 4 hours in self-recorded PEF ≥ 5 % was shown for the 
group with a GM exposure of 8.4 ng/m
3
 (84 EU/m
3
) (LOAEL). The authors de-
fined 1.7 ng/m
3
 (17 EU/m
3
, GM of low-exposure group) as the NOAEL (86, 88).   
Long-term exposure 
Epidemiological studies suggest that chronic endotoxin exposure may lead to chro-
nic bronchitis and reduced lung function. Only in three studies was a quantitative 
dose-effect relationship between endotoxin exposure and lung function parameters 
reported. 
Post et al, 1998, found a dose-effect relationship with an annual FEV1 decline  
of 0.33 ± 0.14 ml (mean ± SE) per ng/m
3
 (or per 10 EU/m
3
) endotoxin exposure in 
a 5-year follow-up study in animal feed workers (98). Post et al, 1998, used the 
same cohort as Smid et al, 1992 (120). In the cross-sectional study of Smid et al, 
an annual FEV1 decline of 0.34 ml per ng/m
3
 was calculated.  
A third dose-effect relationship was found in the cross-sectional study by 
Kennedy et al, 1987. They found an annual FEV1 change in cotton workers of  
- 0.052 ml per ng/m
3
 (or per 10 EU/m
3
) (as converted from -0.778 ml FEV1 per 
ng/m
3
 after a mean of 15 working years) (57). This value is lower than those 
found in the first two studies. 
A possible explanation for the different outcomes might be the presence of 
other constituents in the air that also influenced lung function. Furthermore, in  
the studies of Post et al and Smid et al, but not in that of Kennedy et al, a dose-
effect relationship was also found for FEV1 changes and exposure to dust. A quick 
scan of the amount of endotoxins per μg dust in the air revealed remarkable dif-
ferences. In the Kennedy et al study (origin of endotoxin is cotton), the ratio of  
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ng endotoxin per μg dust is much higher than in the study of Smid et al (origin of 
endotoxin is grain). Endotoxin levels co-varied with dust levels in both studies. 
Therefore, it is assumed that (some specific constituents of) (grain-) dust con-
tributed to the steeper decline in FEV1 in subject exposed in the studies of Post  
et al and Smid et al and that the most accurate dose-effect relationship between 
endotoxin exposure and FEV1 changes is revealed by Kennedy et al. 
Several epidemiological studies have been performed in which workers were 
stratified by exposure levels. Workers with average work histories of 10–20 years 
were exposed to average endotoxin concentrations varying from 2.8 to 520 ng/m
3
 
(28–5 200 EU/m3). Effects of exposure were found on baseline FEV1 for workers 
exposed to 230 ng/m
3
 (2 300 EU/m
3
) or higher (57), but not in workers exposed to 
average endotoxin levels at or below 150 ng/m
3
 (1 500 EU/m
3
) (16, 17). In newly 
hired cotton workers, lung function parameters were affected after one year of 
exposure to average endotoxin levels of 220 ng/m
3
 (2 200 EU/m
3
) or more (134).  
In most studies, workers had respiratory complaints. However, respiratory 
symptoms are quite common as the incidence of respiratory symptoms in the 
normal population can be higher than 30 %. Associations between symptoms and 
endotoxin exposure, or symptoms and lung function changes were highly incon-
sistent and, therefore, conclusions will not be based on uncertain differences in the 
occurrence of symptoms.  
Immunological effects 
Several studies indicated that some people are more sensitive to endotoxins than 
others. This concerns especially atopic asthmatics and other symptomatic atopics, 
as even generally low endotoxin levels in house dust can aggravate asthma or other 
respiratory tract effects. The literature also indicates that asymptomatic atopics are 
equally or even less sensitive to endotoxins than healthy persons. 
No evidence is found for the hypothesis that chronic inhalatory endotoxin ex-
posure may non-specifically encourage sensitisation to antigens in man (adjuvant 
effect). In contrast, endotoxin exposure even at mature age seems to protect against 
the development of atopy. 
In conclusion, the committees note a number of different interactions between 
exposure to endotoxins and atopy or atopic asthma. These different interactions 
comprise 1) an increased susceptibility to endotoxin of symptomatic atopics; 2) the 
protection against development of atopy after exposure to endotoxins. In addition, 
gene-environment interactions; 3) have been observed for respiratory symptoms 
(wheezing). The committees believe that there are several possible mechanisms 
behind the various interactions between exposure to endotoxins and atopy or atopic 
asthma. 
Carcinogenic, reproductive, neurological or endocrine effects 
In the literature, no evidence is found for possible reproductive, neurological or 
endocrine effects. Endotoxins probably do not enter the bloodstream to any great 
extent, which makes an effect on reproductive, neurological or endocrine end-
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points unlikely. Reduced lung cancer rates as a beneficial effect of occupational 
exposure to LPS have been suggested in textile workers. 
8. Existing guidelines, standards and evaluations 
8.1 General population 
There is no recommended exposure limit for airborne endotoxins for the general 
population. 
8.2 Working population 
In 1994, an evaluation on occupational endotoxin exposure was conducted by the 
International Committee on Occupational Health (ICOH), through its Committee 
on Organic Dusts. It was stated that ODTS is elicited at exposure levels of 1 000–
2 000 ng/m
3
 (10 000–20 000 EU/m3), while acute bronchoconstriction occurs at 
levels of 100–200 ng/m3 (1 000–2 000 EU/m3), and mucous membrane irritation 
at levels of 20–50 ng/m3 (200–500 EU/m3). It was also stated that these levels 
may be lower for sensitive subjects (52).  
In the Netherlands, an advice report was written (1998) in order to set a maxi-
mal accepted concentration (MAC) for endotoxins, coming up with a health based 
recommended occupational exposure level of 5 ng/m
3
 (50 EU/m
3
) (41). However, 
no legally binding limit has yet been established.  
9. Hazard assessment 
9.1 Assessment of the health hazard 
Airborne endotoxin exposure, occurring in certain occupational settings, has con-
vincingly been shown to generate biological and clinical effects in man. Exposure 
to endotoxins can cause acute and chronic health effects. The lung appears to be 
the main target organ in which these adverse effects occur. 
Endotoxin exposure has been associated with decreased lung function in several 
experimental and epidemiological studies. The committees consider an across-shift 
FEV1 change as a sensitive and important parameter to indicate lung function 
changes due to inhalation endotoxin exposure in a dose-dependent manner. FEV1 
is known to be the parameter most consistently affected by endotoxin exposure, 
and small decrements in FEV1 are sensitive indicators of respiratory impairment 
and mortality. 
Consequences of decreased lung function in general 
For a good interpretation of data on FEV1, the following considerations are im-
portant: 
- FEV1 decreases with age. 
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- FEV1 decrease is not linear, but the annual decrease in FEV1 increases with  
age and is dependent on sex and standing height (34) (i.e. ± 0.5 % per year for 
20-year old women (34) and ± 0.8 % per year as the mean in men and woman 
from 30 to 60 years (8)). 
- The average FEV1 decline during 40 years is approximately 1 litre in the non-
smoking population, which corresponds to approximately 25–30 ml/year (59). 
- FEV1 exhibits variability over 24-hour periods (diurnal variation) (8). 
- The annual FEV1 decline due to endotoxin exposure decreases with increasing 
working years in an endotoxin-rich environment (17, 98). The annual FEV1 
decrease is higher in chronically symptomatic workers than in asymptomatic 
workers (16, 98). 
 
A WHO working group has recommended criteria for classifying individual 
workers with respect to ventilatory effects caused by exposure to organic dust. 
The working group defined chronic ventilatory effects for an individual as “mild 
to moderate” when FEV1 (measured after an absence from exposure of at least 
two days) is between 60 and 79 % of the reference level, and as “severe” when it 
is less than 60 % of the reference level. Chronic ventilatory impairment is defined 
“absent” in an individual as long as the FEV1 level is over 80 % of the reference 
level (as mentioned in Chattopadhyay et al, 2003 (15)). Using individual FEV1 
values expressed as percentage of predicted for that person (considering its sex, 
standing height and age) can prevent difficulties in interpretation of the data and 
automatically corrects differences due to confounding by one of those parameters. 
Several studies indicate that an average decline in FEV1 (on group level) may 
be a predictor of respiratory morbidity and mortality (3, 30, 44, 106). 
In a 20-year follow-up study in a population of 668 men, an average FEV1 loss 
of 620 ml (compared to the predicted FEV1) was associated with a higher relative 
risk (RR) of developing chronic non-specific lung disease (RR 1.8, 95 % CI 1.27–
2.67), a higher mortality from chronic non-specific lung disease (RR 3.35, 95% CI 
1.23–9.11) and a higher total mortality (RR 1.32, 95 % CI 1.03–1.71). Workers 
with an FEV1 reduction greater than 1 240 ml below the reference level had a con-
siderably higher risk for developing chronic lung disease (RR 12.8, 95 % CI 5.96–
27.5), a higher mortality due to chronic lung disease (RR 25.5, 95 % CI 8.69–75.0) 
and a higher total mortality (RR 2.86, 95 % CI 1.82–4.49) (44).  
Ryan et al, 1999, found that the average FEV1 was significantly associated with 
all-cause mortality and cardiovascular disease mortality in both sexes. An extra 
decline in FEV1 of 50 ml/year increased the risk of death for all causes in women 
by 1.23 (95 % CI 1.06–1.44). In men, the effect of decline in FEV1 on death rate 
was less (106). 
In a study of Sin et al, 2005, it has been shown in a population (n = 1 861, 40–
60 years) that a mean decline of FEV1 to 88 % of the predicted FEV1, is statistical-
ly significantly associated with cardiovascular events. This association was not 
found for a mean decline to 96 % of the predicted FEV1 (117). Assuming a mean 
predicted FEV1 of 3 litres, the committees estimate that no association with cardio-
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vascular effects has to be expected when FEV1 is declined with 120 ml (4 % of 
FEV1).  
However, for the hazard assessment of occupational exposure to endotoxins, 
DECOS and NEG emphasise that effects on lung function on a population level 
should be weighed differently than effects on an individual level. In other words, 
although, for example, a 5 % decrease in FEV1 for an individual person is not 
considered an adverse effect by the WHO, as cited in (15), DECOS and NEG are 
of the opinion that such a decrease in FEV1 on the population level should be con-
sidered adverse because the population will include individuals with considerably 
higher (and lower) decreases.  
Acute and short-term exposure 
Studies concerning effects on lung function of acute and short-term exposure to 
endotoxins are summarised in Table 5 (Section 7.2). Critical studies are compiled 
in Table 7. 
In a study from 1987 by Castellan et al, healthy volunteers, pre-selected for 
being sensitive to LPS, were exposed to cotton dust during 6 hours, with airborne 
endotoxin concentrations ranging from 6 to 779 ng/m
3
 (60–7 790 EU/m3). A zero 
percentage across-shift change in FEV1 at an exposure level of 9 ng/m
3
 (90 EU/ 
m
3
) was calculated (13).  
Milton et al, 1995 and 1996, showed a dose-effect relationship with across-shift 
decreases (> 5 %) over 4 hours in self-recorded PEF of 37 fibreglass workers ex-
posed to 0.4–759 ng/m3 (4–7 590 EU/m3) endotoxin (personal sampling). An effect 
on across-shift changes in FEV1 was also suggested but was not as strong as that 
demonstrated for PEF. A LOAEL of 8.4 ng/m
3
 and a NOAEL of 1.7 ng/m
3
 was 
defined in this study (86, 88). 
The committees consider an across-shift change in FEV1 a more reliable in-
dicator of lung function change than a small decline in self-reported PEF.  
Long-term exposure 
Studies on long-term exposure to endotoxins and adverse human effects on lung 
function are summarised in Table 6 (Section 7.3). Critical studies are compiled in 
Table 7.  
Chronic exposure to endotoxins is a causal factor for chronic airway responses. 
Three studies reported quantitative dose-effect relationships. Smid et al, 1992 
(120) and Post et al, 1998 (98), studying the same cohort of animal feed workers 
(exposed to grain), observed a correlation between annual FEV1 change and endo-
toxin exposure, i.e. -0.34 ml (0.0077 %) per ng/m
3
 (or per 10 EU/m
3
) endotoxins. 
Kennedy et al, 1987, however, found a less steep dose-effect relation in cotton 
workers, i.e. -0.052 ml FEV1 annually per ng/m
3
 (or per 10 EU/ m
3
) endotoxins 
(57). A clear explanation for this difference was not given but a remarkable dif-
ference in dust per endotoxin ratio in air is noted. The dust per endotoxin ratio 
was approximately 100 times higher in the studies of Smid et al (120) and Post  
et al (98) than in that of Kennedy et al (57). This might suggest that other con-
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stituents in the air are responsible for the steeper decrease in FEV1 in the study  
of Smid et al and Post et al. In addition, also some methodological differences 
between the studies may have played a role. 
Christiani et al, 2001, found a statistically significant relationship between 
acute (across-shift) changes in FEV1 and annual changes in FEV1 (16). The 
findings were, however, independent from exposure to endotoxins. It is thought 
that the correlation between chronic and acute FEV1 decrease is more likely 
caused by variability in sensitivity of the respiratory tract between subjects than 
by the level of endotoxin exposure. This leads to changes in acute ΔFEV1 and in 
the long run to chronic FEV1 decreases. 
Latza et al, 2004, found a dose-effect relation between exposure to endotoxins 
and respiratory symptoms (wheezing and coughing) (69). The result suggests a 
clear dose-dependent increase in respiratory symptoms after exposure to endo-
toxin levels between 100 and 450 EU/m
3
, with significant effects after exposure  
to levels that exceeded 450 EU/m
3
. The low-exposure group (< 100 EU/ m
3
) was 
used as controls. Therefore, NOAELs or LOAELs cannot be derived. 
Other adverse or beneficial effects after long-term exposure 
No information is available concerning adverse effects of inhalatory exposure to 
endotoxins on reproduction, neurological, endocrine or other systemic parameters. 
Cancer risks have been investigated in relation to occupational exposure to endo-
toxins. Reduced risks for lung cancer have been reported in several epidemiological 
studies since the 1970s. The most recent finding of Astrakianakis et al from 2007 
suggests an inverse relation between cancers of the lung and endotoxin exposure 
in the textile industry as well (4). No biological explanation for this finding has 
been given yet. 
Recent studies suggest that environmental endotoxin exposure might protect 
against the development of atopy and asthma. A lower prevalence for atopy and 
hay fever has been observed in farmer’s children and in adolescents with farmers’ 
background compared to those without a farmer’s background. Negative exposure 
response relations have also been observed (97). However, on the other hand, 
occupational exposure to endotoxins is a risk factor for wheeze and bronchial 
hyperresponsiveness and these symptoms have most often a non-atopic back-
ground, independent on the presence of allergy. Asthma-like disorders are induced 
by occupational exposure to endotoxins in the absence of atopic sensitisation and 
a recent analysis indicated that the attribution of symptoms to atopy is small in 
highly endotoxin exposed populations (97, 121). 
In conclusion, there is considerable reason for caution for interpreting as-
sociations between atopy and endotoxin exposure. Furthermore, DECOS and 
NEG do not take the possible health benefits into account for the quantitative 
health assessment after occupational exposure. 
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Conclusion 
The critical study regarding lung function effects from acute exposure is the study 
by Castellan et al (13), in which linear regression analysis indicated that 90 EU/m
3
 
(9 ng/m
3
) is the highest level at which no across-shift change in FEV1 occurs 
(NOAEL). By combining this result with those from long-term studies, it is 
possible to judge whether this level can also be regarded as a NOAEL for lung 
function effects after chronic occupational exposure. Applying the results by 
Castellan et al to the data of Smid et al and Post et al (98, 120) implies that 40 
years of exposure to 90 EU/m
3
 (9 ng/m
3
) endotoxins cause an extra decline in 
FEV1 of 120 ml. If one instead applies the data of Kennedy et al (57), in the same 
way, a more than 10-fold lower decline is implied. The committees consider an 
extra decline of 120 ml over 40 years to be a non-adverse effect, in view of the 
average age-related decrease of about 1 litre in non-smokers over the same period.  
9.2 Groups at extra risk 
Groups suffering from COPD and groups with atopic asthma and atopic respiratory 
disease have an increased risk of aggravation of respiratory symptoms and other 
acute pulmonary effects at endotoxin levels that would not affect “normal” healthy 
workers. Furthermore, smokers may be more sensitive for endotoxin insults than 
non-smokers. 
9.3 Scientific basis for an occupational exposure limit 
The critical effect of endotoxin inhalation exposure is considered to be impaired 
lung function. Data indicates that no adverse FEV1 decline is expected from long- 
term exposure up to approximately 90 EU/m
3
 (9 ng/m
3
).  
It is recommended to measure endotoxins by using the most recent version of 
the LAL-assay (NEN-EN 14031 procedure with adjustments by Spaan et al, 2007) 
as older methods tend to underestimate the exposure. 
10. Recommendations for research 
There are no recommendations for further research. 
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Table 7. Critical studies with a dose-effect relation between endotoxin exposure and adverse effects on lung function. 
Study design and population Work history
 a
 Endotoxin exposure, range Effect/NOAEL based on  Reference  
Experimental exposure (6 h)  
of healthy volunteers, pre-selected for being 
reactive to endotoxins, n = 33–61  
- 6–779 ng/m3 
(60–7 790 EU/m3) 
0 % across-shift change in FEV1 at 9 ng/m
3
 (90 EU/m
3
). (13) 
 
Cross-sectional,  
cotton mill workers, n = 443 
silk workers, n = 439 (controls) 
15 yrs 2, 100, 230, 520 ng/m
3
  
(20, 1 000, 2 300, 5 200 EU/m
3
) 
Annual FEV1 change: 
-0.016 to -0.052 ml per ng/m
3
 or per 10 EU/m
3
. 
b
 
(57)  
Cross-sectional,  
animal feed workers, n = 265 
non-exposed colleagues, n = 50 
13 yrs 0.2–470 ng/m3 
< 15, 30–40, 67 ng/m3  
(< 150, 300–400, 670 EU/m3) 
Annual FEV1 change:  
-0.34 ml per ng/m
3
 or per 10 EU/m
3
. 
(120)  
5-year follow-up 
animal feed industry workers, n = 140  
no controls 
(same cohort as above) 
12.5 ± 8 yrs 3.6–99 ng/m3  
(36–990 EU/m3) 
Annual FEV1 change:  
-0.33 ml per ng/m
3
 or per 10 EU/m
3
. 
(98) 
 
a 
At the start date of the study. 
b 
For comparability with other studies, -0.242 to -0.778 ml FEV1 per ng/m
3
 over 15 years has been converted to annual FEV1 change. 
EU: endotoxin unit, FEV1: forced expiratory volume in 1 second, NOAEL: no observed adverse exposure level.  
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11. Summary  
The Nordic Expert Group for Criteria Documentation of Health Risks from 
Chemicals and the Dutch Expert Committee on Occupational Safety. 
144. Endotoxins. Arbete och Hälsa 2011;45(4):1-53. 
 
Endotoxins are components of the outer membrane of Gram-negative bacteria and 
are a biologically active component in most organic dusts. Occupational exposure 
occurs primarily in the agriculture industry and related sectors. 
Endotoxin levels in air can be measured either in absolute terms (weight/m
3
) or 
as functional (bioactive) levels. The latter can be measured by use of the Limulus 
amebocyte lysate assay and levels are expressed as endotoxin units (EU)/m
3
. 
Endotoxins that enter the upper respiratory tract are expelled by means of muco-
ciliary transport. Smaller particles deposit in the deeper airways and are locally 
phagocytised by macrophages, a process that may result in inflammatory reactions. 
Therefore, systemic effects due to inhaled endotoxins are most likely induced by 
cytokines that are released from the lung into the blood. 
Airborne endotoxin exposure has been shown to generate biological and clinical 
effects in man. The lung appears to be the main target organ and endotoxin ex-
posure has been associated with decreased lung function in several experimental 
and epidemiological studies. Acute effects in humans after endotoxin inhalation 
are dry cough and shortness of breath accompanied by decreased lung function, 
fever reactions and malaise, and sometimes dyspnoea, headache and joint aches 
occurring a few hours after exposure. Chronic endotoxin exposure may lead to 
chronic bronchitis and reduced lung function.  
Forced expiratory volume in 1 second (FEV1) is known to be the parameter 
most consistently affected by endotoxin exposure, and small decrements in FEV1 
are early and sensitive indicators of respiratory impairment. 
A clear exposure-effect relationship for the percentage change in FEV1 was 
found in healthy volunteers (pre-selected for being sensitive to endotoxin) ex-
posed to endotoxins for 6 hours. The study indicated that 90 EU/m
3
 (9 ng/m
3
) is 
the highest level at which no acute across-shift change in FEV1 occurs. This result 
was combined with those from long-term studies. The extra decline in FEV1 after 
40 years of exposure to 90 EU/m
3
 endotoxin was calculated to be up to 120 ml, 
which was considered as a non-adverse effect.  
In conclusion, no adverse health effects are expected after chronic occupational 
exposure at 90 EU/m
3
.  
 
 
 
 
 
Keywords: endotoxin, lipopolysaccharide, lung function, occupational exposure 
limit, respiratory effects, review, risk assessment, toxicity  
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12. Summary in Swedish 
The Nordic Expert Group for Criteria Documentation of Health Risks from 
Chemicals and the Dutch Expert Committee on Occupational Safety. 
144. Endotoxins. Arbete och Hälsa 2011;45(4):1-53. 
 
Endotoxiner är beståndsdelar i cellväggen hos Gram-negativa bakterier och är en 
biologiskt aktiv komponent i de flesta typer av organiskt damm. Yrkesmässig ex-
ponering för endotoxiner förekommer framför allt inom jordbrukssektorn och där-
till knutna industrier. 
Nivåerna av endotoxiner i luft kan mätas i absoluta termer (vikt/m
3
) eller som 
funktionella, bioaktiva nivåer. De senare kan mätas med hjälp av Limulus amöbo-
cytlysat-metoden och anges i endotoxinenheter (EU)/m
3
. 
Vid inandning av endotoxiner deponeras dessa i andningsvägarna. Vid depo-
nering i luftstrupen och bronkerna transporteras partiklarna bort av flimmerhåren. 
Mindre partiklar fastnar i de nedre luftvägarna där de fagocyteras av makrofager 
vilket kan utlösa inflammatoriska reaktioner. Systemiska effekter orsakas därför 
troligen av cytokiner som frisätts från lungan ut i blodet. 
Luftburna endotoxiner ger upphov till biologiska och kliniska effekter på män-
niska. Lungorna tycks vara det viktigaste målorganet och exponering för endo-
toxiner har satts i samband med försämrad lungfunktion i flera experimentella och 
epidemiologiska studier. Akuta hälsoeffekter efter inandning är torrhosta och and-
fåddhet åtföljt av försämrad lungfunktion, feber och sjukdomskänsla, samt ibland 
andnöd, huvudvärk och ledvärk som uppträder några timmar efter exponeringen. 
Epidemiologiska studier antyder att kronisk exponering för endotoxiner kan leda 
till kronisk bronkit och försämrad lungfunktion. 
Forcerad exspiratorisk volym under första sekunden (FEV1) anses vara en till-
förlitlig parameter för att påvisa effekter av endotoxiner och små försämringar av 
FEV1 är tidiga och känsliga indikatorer på luftvägsbesvär. Tydliga dos-effekt-
samband för den procentuella förändringen i FEV1 observerades hos friska fri-
villiga (utvalda för att vara känsliga för endotoxiner) som exponerades för endo-
toxiner i 6 timmar. Studien indikerade att 90 EU/m
3
 (9 ng/m
3
) är den högsta nivå 
som inte ger upphov till akuta förändringar i FEV1 över ett arbetspass. I kombina-
tion med data från långtidsstudier kan det beräknas att exponering i 40 år för 90 
EU/m
3
 ger en extra sänkning av FEV1 på upp till 120 ml, vilket inte anses vara 
skadligt. 
Sammanfattningsvis bedöms yrkesmässig långtidsexponering för 90 EU/m
3
 inte 
ge upphov till skadliga hälsoeffekter. 
 
 
 
 
Nyckelord: endotoxin, hygieniskt gränsvärde, lipopolysackarid, lungfunktion, 
respiratoriska effekter, riskbedömning, toxicitet, översikt   
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14. Data bases used in the search for literature 
This report has been based on scientific data, which are publicly available. Data 
were mainly obtained from the online database MEDLINE, using endotoxins and 
LPS as main key words and many additional search terms for refinement. The 
search was performed for the period January 1996 till May 2004. An additional 
search was performed in January 2010 using the following keywords: endotoxin, 
health effects and occupational. 
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NEG criteria documents published in the scientific serial Arbete och Hälsa (Work and 
Health): 
Substance/Agent Arbete och Hälsa issue 
Acetonitrile 1989:22, 1989:37* 
Acid aerosols, inorganic 1992:33, 1993:1* 
Acrylonitrile 1985:4 
Allyl alcohol 1986:8 
Aluminium 1992:45, 1993:1* 
Ammonia 1986:31, 2005:13* 
Antimony 1998:11* 
Arsenic, inorganic 1981:22, 1991:9, 1991:50* 
Arsine 1986:41 
Asbestos 1982:29 
Benomyl 1984:28 
Benzene 1981:11 
1,2,3-Benzotriazole 2000:24*D 
Boric acid, Borax 1980:13 
1,3-Butadiene 1994:36*, 1994:42 
1-Butanol 1980:20 
γ-Butyrolactone 2004:7*D 
Cadmium 1981:29, 1992:26, 1993:1* 
7/8 Carbon chain aliphatic monoketones 1990:2*D 
Carbon monoxide 1980:8 
Ceramic Fibres, Refractory 1996:30*, 1998:20 
Chlorine, Chlorine dioxide 1980:6 
Chloromequat chloride 1984:36 
4-Chloro-2-methylphenoxy acetic acid 1981:14 
Chlorophenols 1984:46 
Chlorotrimethylsilane 2002:2 
Chromium 1979:33 
Cobalt 1982:16, 1994:39*, 1994:42 
Copper 1980:21 
Creosote 1988:13, 1988:33* 
Cyanoacrylates 1995:25*, 1995:27 
Cyclic acid anhydrides 2004:15*D 
Cyclohexanone, Cyclopentanone 1985:42 
n-Decane 1987:25, 1987:40* 
Deodorized kerosene 1985:24 
Diacetone alcohol 1989:4, 1989:37* 
Dichlorobenzenes 1998:4*, 1998:20 
Diesel exhaust 1993:34, 1993:35* 
Diethylamine 1994:23*, 1994:42 
2-Diethylaminoethanol 1994:25*N 
Diethylenetriamine 1994:23*, 1994:42 
Diisocyanates 1979:34, 1985:19 
Dimethylamine 1994:23*, 1994:42 
Dimethyldithiocarbamates 1990:26, 1991:2* 
Dimethylethylamine 1991:26, 1991:50* 
Dimethylformamide 1983:28 
Dimethylsulfoxide 1991:37, 1991:50* 
Dioxane 1982:6 
Enzymes, industrial 1994:28*, 1994:42 
Epichlorohydrin 1981:10 
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Ethyl acetate 1990:35* 
Ethylbenzene 1986:19 
Ethylenediamine 1994:23*, 1994:42 
Ethylenebisdithiocarbamates and Ethylenethiourea 1993:24, 1993:35* 
Ethylene glycol 1980:14 
Ethylene glycol monoalkyl ethers 1985:34 
Ethylene oxide 1982:7 
Ethyl ether 1992:30* N 
2-Ethylhexanoic acid 1994:31*, 1994:42 
Flour dust 1996:27*, 1998:20 
Formaldehyde 1978:21, 1982:27, 2003:11*D 
Fungal spores 2006:21* 
Furfuryl alcohol 1984:24 
Gasoline 1984:7 
Glutaraldehyde 1997:20*D, 1998:20 
Glyoxal 1995:2*, 1995:27 
Halothane 1984:17 
n-Hexane 1980:19, 1986:20 
Hydrazine, Hydrazine salts 1985:6 
Hydrogen fluoride 1983:7 
Hydrogen sulphide 1982:31, 2001:14*D 
Hydroquinone 1989:15, 1989:37* 
Industrial enzymes 1994:28* 
Isoflurane, sevoflurane and desflurane 2009;43(9)* 
Isophorone 1991:14, 1991:50* 
Isopropanol 1980:18 
Lead, inorganic 1979:24, 1992:43, 1993:1* 
Limonene 1993:14, 1993:35* 
Lithium and lithium compounds 2002:16* 
Manganese 1982:10 
Mercury, inorganic 1985:20 
Methacrylates 1983:21 
Methanol 1984:41 
Methyl bromide 1987:18, 1987:40* 
Methyl chloride 1992:27*D 
Methyl chloroform 1981:12 
Methylcyclopentadienyl manganese tricarbonyl 1982:10 
Methylene chloride 1979:15, 1987:29, 1987:40* 
Methyl ethyl ketone 1983:25 
Methyl formate 1989:29, 1989:37* 
Methyl isobutyl ketone 1988:20, 1988:33* 
Methyl methacrylate 1991:36*D 
N-Methyl-2-pyrrolidone  1994:40*, 1994:42 
Methyl-tert-butyl ether 1994:22*D 
Microbial volatile organic compounds (MVOCs) 2006:13* 
Microorganisms 1991:44, 1991:50* 
Mineral fibers 1981:26 
Nickel 1981:28, 1995:26*, 1995:27 
Nitrilotriacetic acid 1989:16, 1989:37* 
Nitroalkanes 1988:29, 1988:33* 
Nitrogen oxides 1983:28 
N-Nitroso compounds 1990:33, 1991:2* 
Nitrous oxide 1982:20 
Occupational exposure to chemicals and hearing impairment 2010;44(4)* 
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Oil mist 1985:13 
Organic acid anhydrides 1990:48, 1991:2* 
Ozone 1986:28 
Paper dust 1989:30, 1989:37* 
Penicillins 2004:6* 
Permethrin 1982:22 
Petrol 1984:7 
Phenol 1984:33 
Phosphate triesters with flame retardant properties 2010;44(6)* 
Phthalate esters 1982:12 
Platinum 1997:14*D, 1998:20 
Polyethylene,  1998:12* 
Polypropylene, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polystyrene, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polyvinylchloride, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polytetrafluoroethylene, Thermal degradation products in 
the processing of plastics 
1998:12* 
Propene 1995:7*, 1995:27 
Propylene glycol 1983:27 
Propylene glycol ethers and their acetates 1990:32*N  
Propylene oxide 1985:23 
Refined petroleum solvents 1982:21 
Refractory Ceramic Fibres 1996:30* 
Selenium 1992:35, 1993:1* 
Silica, crystalline 1993:2, 1993:35* 
Styrene 1979:14, 1990:49*, 1991:2 
Sulphur dioxide 1984:18 
Sulphuric, hydrochloric, nitric and phosphoric acids 2009;43(7)* 
Synthetic pyretroids 1982:22 
Tetrachloroethane 1996:28*D 
Tetrachloroethylene 1979:25, 2003:14*D 
Thermal degradation products of plastics 1998:12* 
Thiurams 1990:26, 1991:2* 
Tin and inorganic tin compounds 2002:10*D 
Toluene 1979:5, 1989:3, 1989:37*, 2000:19* 
1,1,1-Trichloroethane 1981:12 
Trichloroethylene 1979:13, 1991:43, 1991:50* 
Triglycidyl isocyanurate 2001:18* 
n-Undecane 1987:25, 1987:40* 
Vanadium 1982:18 
Vinyl acetate 1988:26, 1988:33* 
Vinyl chloride 1986:17 
Welding gases and fumes 1990:28, 1991:2* 
White spirit 1986:1 
Wood dust 1987:36 
Xylene 1979:35 
Zinc 1981:13 
* in English, remaining documents are in a Scandinavian language.  
D = collaboration with the Dutch Expert Committee on Occupational Safety (DECOS).  
N = collaboration with the US National Institute for Occupational Safety and Health (NIOSH).  
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